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Patricia A. Vignaux: A modular Chromatin in vivo Assay reveals the influence of promoter 
structure on heterochromatin memory 
(Under the direction of Nathaniel Hathaway) 
The genomes of eukaryotic organisms exist in a highly-organized state 
compartmentalized within the nucleus, packaged with histones and other proteins in a complex 
called chromatin. Early discoveries revealed chromatin conformation can affect gene expression 
by studying transposition of the white gene in Drosophila. Open euchromatic regions of the 
chromosome arm contained more active genes, while heterochromatic closed regions adjacent to 
the centromere correlated with gene repression. Since that time, researchers have consistently 
used reporter genes with measurable gene products such as the green fluorescent protein as tools 
to study transcriptional activation and repression to uncover the chromatin environment of the 
reporter gene. Here, we report the creation of a modular Chromatin in vivo Assay designed to 
explore the influence that differences in the DNA sequence or the aforementioned accessory 
proteins have on the formation and stability of a heterochromatin state. This assay allows for the 
recruitment of proteins that can modify the chromatin state of a reporter gene, thus influencing 
transcriptional output of the gene. We demonstrate that promoter structure, determined by 
presence or absence of CpG dinucleotides in the DNA sequence, has little influence on the 
ability of the chromatin effector protein heterochromatin protein 1 (HP1) to induce short-term 
heterochromatin in mouse embryo fibroblasts as measured by transcriptional silencing and the 




an impact on the ability of the cells to maintain long-term transcriptional silencing after repeated 
rounds of cell division, termed heterochromatin memory. We also used this assay to demonstrate 
that the newly-characterized chromatin effector protein m-phase phosphoprotein 8 (MPP8) is 
capable of inducing transcriptional silencing, albeit less efficiently than HP1.  This assay has 
proven to be a useful tool in elucidating the proteins and pathways that are required for gene 
silencing and heterochromatin formation and we anticipate its continued use in characterizing the 
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CHAPTER 1: Introduction  
 
1.1. Reporter transgenes as sensors for the chromatin landscape 
The DNA of eukaryotic organisms is highly compacted, organized and regulated by a host of 
nuclear proteins. This complex of DNA and its associated proteins is termed chromatin, and it 
can exist in at least two general states: euchromatin and heterochromatin. Euchromatin is the 
more “open” chromatin conformation, characterized by less nucleosomal compaction and more 
transcriptional activity. Heterochromatin, or “closed” chromatin, is tightly physically compacted 
and usually transcriptionally repressed 1. These two states of chromatin were first identified 
cytologically, as heterochromatin was identified by darker staining under the microscope 2, but 
we now have more sophisticated means of differentiating the two. One is by measuring 
nucleosome compaction 1,3,4, and another is by identifying characteristic alterations to the DNA-
packaging histone proteins . Covalent adjuncts to histone proteins comprise a molecular code 
that is responsible for regulating the expression of the underlying DNA sequence.   
These adjuncts are called histone post-translational modifications, and the majority occur 
on the flexible peptide tails of the histone proteins. Common modifications include the addition 
of methyl, acetyl, phosphoryl, or ubiquityl groups. Combinations of these individual 
modifications create a complex instruction manual for the regulatory proteins servicing the 
genome 5. Interpreting these combinations is a strategy used by many to identify regulatory 
regions of the human genome. Cis-regulatory elements like promoters and enhancers display 




precipitation (ChIP) 6.  Many studies still rely on the activity of reporter genes to identify novel 
regulatory elements 7. A reporter gene is a gene whose protein product is easily identified and 
can serve as a marker for gene expression. Reporter genes are typically transgenes, which are 
made from the cDNA of one organism and introduced through transfection, infection, or 
injection into the target cells of another organism 8. Because the functions of promoters and 
enhancers are inextricable from the histone post-translational marks that confer their functions, 
the gene regulatory readout of a reporter gene is actually a proxy for the chromatin landscape of 
the region in which the gene resides. We present here a brief history of such chromatin reporter 
genes focusing on how they have been used as sensors to identify functional elements and genes 
that control gene expression, as well as helped develop tools to monitor protein-protein 
interactions and exert control on the surrounding chromatin. 
1.2. Position effect variegation and the white gene   
One of the first and most well-characterized reporter genes was not a transgene in the 
traditional sense, in that it did not come from a different organism. The white gene in Drosophila 
melanogaster codes for a transporter enzyme that belongs to the ATP-dependent binding cassette 
transporter superfamily and is responsible for transporting the precursors of pigments into the 
pigment cells in the Drosophila eye 9.  Mutation or silencing of the white gene results in a loss of 
pigment deposition, resulting in a fly with white eyes instead of the wild-type red. In 1930, the 
phenomenon of position effect variegation (PEV) was described using the white gene. When 
exposed to X-ray irradiation, an arm of the X chromosome became translocated and, while the 
white gene was not damaged, it became transcriptionally silenced in a subset of cells. This 
resulted in a fly with patches of red and white cells, called “mottled” or “variegated,” instead of 




the white gene from the euchromatin of the chromosome arm to a region adjacent to the 
heterochromatin of the centromere. In a subset of cells, the heterochromatin spread from the 
centromere to the new locus of the white gene, silencing transcription of the gene in those cells 
11–13.  
The extent of the heterochromatin spread was determined early in development, and all 
the subsequent clones of each cell followed the same transcriptional plan. In essence, the white 
gene was a reporter for the spread of heterochromatin in these cells 14. This new reporter gene 
was quickly exploited when it was discovered that some secondary mutations produced by X-ray 
irradiation, ethyl methanesulfonate (EMS), or P element-induced mutagenesis, could suppress or 
enhance PEV, resulting in increasing or decreasing variegation, respectively 13,15–19. Two of the 
earliest identified suppressors of variegation (Su(var)) mutations were Su(var)205 and Su(var)3-
9 18,20. The Su(var)205 mutation was allelic with the Su(var)2-5 mutation, and both mutations 
mapped to the coding sequence of heterochromatin protein 1 (HP1), later renamed HP1a 21–23. 
This gene coded for a non-histone protein that was associated with the heterochromatic regions 
of Drosophila chromosomes and was integral to maintaining a heterochromatin structure 24. The 
Su(var)3-9 mutations were identified along with a cluster of other mutations on the third 
chromosome that also suppressed the variegated phenotype. They all mapped to an unknown 
protein coding gene, also named Su(var)3-9, that contained an N-terminal chromo-domain and a 
C-terminal homology to the trithorax and Enhancer of zeste family protein products, a region 
later termed the Su(var)3-9, Enhancer-of-zeste and Trithorax (SET) domain 17,25.  
The role of white as a reporter gene was further solidified when it was cloned between the 
terminal inverted repeats of a P element. A P element is a DNA transposon that can be mobilized 




are not completely random, they have been instrumental in identifying and mapping essential 
genes throughout the Drosophila genome 26. If a male fly with a mutant copy of white contains a 
P element with an active white transgene, the fly will have wild-type red eyes. If the P element is 
inserted into an area of heterochromatin, the white transgene will be silent and the fly will have 
white eyes. This mobility allowed for the exploration of other heterochromatic regions of the 
genome, such as telomeres and the heterochromatinized fourth chromosome. In several of these 
studies, HP1 mutations were sufficient to suppress variegation when the white gene was 
transposed to the pericentromere or the fourth chromosome, but not the telomeres of the second 
or third chromosome 27,2829,30.  Instead, mutations in the Su(z)2 and Psc genes, interchangeable 
members of the Polycomb Repressive Complex 1, were found to be suppressors of telomeric 
heterochromatin 30. This discovery suggested that the heterochromatin domains at the 
pericentromere and the telomeres, though all constitutive heterochromatin, were not all governed 
by the same molecular processes, and that enzymes previously uncharacterized as suppressors of 
variegation could have some influence on heterochromatin and gene silencing in other regions of 
the genome.  
Many of the proteins identified as suppressors of variegation became well known as 
integral components of heterochromatin formation and stability, with paralogs present in 
organisms from yeast to human (Table 1.1) 31. Su(var)3-9 encodes a histone methyltransferase 
that trimethylates the lysine 9 of histone H3 32,33. This H3K9me3 mark is a hallmark trait of 
constitutive heterochromatin, and can be bound by the chromodomain of several 
heterochromatin-associated proteins, like HP1 34,35. HP1 binds the H3K9me3 mark, then recruits 
in more histone methyltransferases to perpetuate the histone mark and create more binding 




formation can “spread” along a chromosome. The other Drosophila H3K9 methyltransferase 
DmSETDB1 is also a suppressor of variegation, though only for chromosome 4, and the protein 
was discovered before the PEV phenotype 39. As technology progressed, and it became easier to 
clone genes from cDNA, there was a switch from identifying genes through PEV, to validating 
known genes as suppressors of PEV. Other enzymes that are suppressors of variegation include 
the histone H3K4 demethylase Su(var)3-3, which removes methyl groups from H3K4 mono- or 
dimethylated histones, a function that closely linked to the regulation of methylation of H3K9, 
and the histone deacetylase HDAC1, whose histone deacetylase activity of the lysine residues on 
histones are required for subsequent methylation of those same residues 40,41. Unsurprisingly, 
mutations in the gene encoding the Drosophila S-adenosylmethionine synthetase also suppress 
variegation, as this enzyme is responsible for synthesizing the substrate for methyl-group 
transfers 42.  
The evaluation of PEV in general, and the white gene specifically, have been powerful 
tools in uncovering the hidden processes of heterochromatin formation and stability. There were 
limitations to this system, however: white is only easily detectable in Drosophila, in the eye, and 
one study found the white gene may be particularly sensitive to silencing, compared to 
surrounding genes 43. Concurrently, novel transgenes were being discovered and explored as 
alternative chromatin sensors, ones that could be transplanted into other model organisms in 
order to easily evaluate the transcriptional landscape of the genomic insertion and follow 





1.3. Investigating gene expression profiles with reporter genes  
The lacz gene, which encodes the enzyme β- galactosidase, is one component of the 
revelatory lactose (lac) operon from Escherichia coli. The lac operon was the first gene 
expression regulatory mechanism to be deciphered in any organism and was a key example of cis 
and trans regulatory elements in prokaryotes 8. β- galactosidase is a tetrameric enzyme that 
cleaves the disaccharide lactose into the monosaccharides glucose and galactose for ATP 
production. While insertion of this transgene will enable lacz mutants to grow on lactose 
medium, its true value as a reporter gene comes from the ability to cleave 5-bromo-4-chloro-3- 
indoyl-b-D-galactopyranoside (X-gal) into galactose and indoxyl molecules, which oxidize and 
dimerize to form an insoluble blue indigo dye 44–46. This reaction is used regularly in bacterial 
cloning protocols for “blue-white” screening but has also been invaluable in monitoring gene 
expression in eukaryotes. The reaction can be detected by a colorimetric assay using a 
spectrophotometer for cell based assays or by histological staining in tissues 47. If assayed with 
fluorescein di-β-D- galactopyranoside instead of X-gal, the cleavage reaction will yield the 
fluorescent molecule fluorescein, which can be a selectable marker for fluorescent activated cell 
sorting 48,49.  
While the lacz gene was also a reporter in used PEV studies in Drosophila 50,51, the 
majority of β-galactosidase studies centered on characterizing gene expression patterns instead of 
suppressors of variegation 52,53. The expression and detection of β-galactosidase activity was 
instrumental in the exploration of cis regulatory elements like promoters and enhancers in 
Drosophila and other model organisms. Gene-adjacent sequences were frequently cloned 
upstream of the lacz gene in expression vectors to determine if they were sufficient to drive gene 
expression 54–57. Deletions and mutations of theses sequences helped characterize the borders of 




tissue specificity in whole organisms 58–60. Researchers also created fusion proteins to “tag” an 
endogenous gene product with β-galactosidase activity in order to follow the expression of this 
gene through embryonic development 53,61–64. This allowed for tracking of cell fate decisions 
during embryogenesis, as well as staining of entire organ systems in a developing embryo. 
Experimentation with lacz transgene arrays in mouse embryos displayed the phenomenon of 
decreased gene expression from arrays with higher gene copy number, a phenomenon that was 
already seen in Drosophila but with the added structural element of DNA hypermethylation of 
the array 65. Like the white gene, lacz has also been used to investigate the expression pattern of 
other chromatin-associated proteins, like the histone methyltransferase Setdb1 and the chromatin 
remodeler SMARCB1 60,63. A down-side of the lacz reporter gene is that some tissues in model 
organisms display very low levels of endogenous β-galactosidase activity and exogenous 
expression must be distinguished through modulation of pH during X-Gal exposure 66. 
Other enzyme-based reporter systems developed during this time employed the cat, luc, 
and gusA genes. The cat gene from E. coli encodes an enzyme called chloramphenicol 
acetyltransferase (CAT), which confers resistance to the antibiotic chloramphenicol and 
catalyzes the transfer of acetyl groups from acetyl coenzyme A to the chloramphenicol 
molecules 67–69. Initial studies using CAT as a reporter gene used thin layer chromatography and 
autoradiography to detect acetylation of chloramphenicol as a molecular readout for gene 
expression 70–72. More recent uses of the gene use a commercially available ELISA kit, but both 
techniques require lysing the cells to measure enzymatic activity in the extract 73. The luc gene 
refers to the specific “firefly luciferase” gene from Photinus pyralis, as opposed to unrelated 
luciferases found in bioluminescent bacteria and cnidarians 74–77. Firefly luciferase catalyzes the 




this reaction are oxyluciferin, CO2 and light, and expression of the luciferase transgene can be 
readily measured with a luminometer or a scintillation counter 78. While most applications of this 
assay also require cell lysates, in vivo expression in cell lines or whole organisms has been 
achieved by direct injection of the luciferin substrate to the system 79–82 .  The gusA gene from E. 
coli is unique among the mentioned transgenes because it is used almost exclusively in plants, 
where the expression of the gene product β-glucuronidase is usually absent. The enzyme can 
cleave most glucoronides, and therefore the gusA transgene can be measured through a variety of 
different substrates 83,84. The most popular is 5-Bromo-4-chloroindoxyl-b-D- glucuronide or, X-
gluc, which creates an indigo blue color on cleavage. Other substrates can create pink or magenta 
dyes, as well as chemiluminescent or fluorescent products 46,85.  
What these enzyme-based reporter gene systems all have in common is that they require a 
substrate to be introduced or present for detection of the reporter gene expression. Unlike the 
white gene, whose expression pattern elicited an observable phenotype in a living organism, 
most of the applications of the enzymatic reporter genes required tissues to be lysed or fixed to 
determine reporter gene expression. Discovery of a substrate-free reporter gene green fluorescent 
protein (GFP) that was not cytotoxic and could be detected in live cells, tissues and whole 
animals was a revolutionary step in the study of regulators of gene expression.  
The GFP that is most widely used in molecular biology originates from the jellyfish 
Aequorea victoria. Researchers were surprised to find that the aequorin luciferase they purified 
from the green bioluminescent animal emitted a blue light. It was later discovered that the green 
hue was the result of a fluorescent protein, GFP, that was excited by the blue light from aequorin 
and emitted in the green spectrum 86,87. Once the gene was cloned and transfected into other 




protein or any other enzymes from jellyfish to function, but instead could be elicited by blue or 
UV light 88,89. The fluorescence of GFP is conferred by three amino acids, serine, tyrosine and 
glycine at residues 65-67, that undergo oxidation and cyclization and form a ρ- 
hydroxybenzylideneimidazolidinone chromophore 90. Random and targeted mutations of the 
amino acid sequence of GFP were performed in order to alter the maximum excitation and 
emission spectra, as well as the expression efficiency of the gene 90–94. A new protein, EGFP, 
was finally engineered to use human-optimized codons for expression and have a maximum 
excitation at 489 nm, which made it compatible for standard FACS and fluorescent microscopy 
experiments 95,96.   
 The first experiments using GFP as a transgene were conducted in E. coli, but the first 
use of GFP as reporter gene took place in C. elegans 88,89,97.  GFP was placed under the control 
of the neural-specific mec-7 promoter, and the resulting fluorescent pattern recapitulated the 
known mec-7 expression pattern at different stages in the developing worm. Because GFP 
protein detection did not require an exogenous substrate, the authors predicted it would be “an 
excellent means for monitoring gene expression and protein localization in living cells.”97 Their 
prediction came true, and the protein has been used to track living cells during embryogenesis in 
mice, zebrafish, flies, and plants 98–107. GFP expression was placed under known lineage-specific 
promoters, like Oct4 in primordial germ cells 108,109 or Math1 in neural progenitors 110, or used to 
find novel lineage-specific regulatory sequences, like in enhancer-trap experiments in the 
translucent zebrafish 111,112. GFP-fusion proteins have been used to visualize the movement of 
cellular structural components, like actin, myosin, and tubulin 113–118, but have also been used to 




Non-histone chromatin proteins and chromatin-modifying enzymes have been the subject 
of much study using GFP fusions. GFP has tagged all mammalian isoforms of HP1 121–126, as 
well as HP1 in other species like Xenopus and fission yeast 38,127. Other chromatin modifying 
proteins that have been tagged with GFP include the histone methyltransferases SETDB1/ESET, 
SUV39H1, SUV39H2, G9A, GLP, and SUV420H2, the histone demethylases KDM4/JMJD2A-
C, and other chromatin related proteins like the polycomb group protein BMI1 and the zinc 
finger protein ZFP296 37,122,128–132. Fusion proteins have also been constructed to visualize the 
proteins involved in the propagation and interpretation of DNA methylation, like the DNA 
methyltransferase DNMT1, or the methyl CpG binding proteins MECP2 and MBD1-3 37. In fact, 
GFP has been used extensively in the study of DNA methylation 133–140, from the effect of CpG 
composition on the long-term expression of transgenes to the effect of DNA methylation on 
nuclear organization to the patterns of DNA methylation during pluripotency and differentiation 
119,141–145. 
These reporter genes were instrumental in characterizing cis regulatory elements, gene 
expression patterns, and protein cellular organization. However, they were also critical for 
characterizing the function of the proteins that controlled transcriptional regulation in a very 
important molecular tool, the GAL4-UAS system. 
 
1.4. The Gal4-UAS system of gene activation  
 
Much like the lac operon in E. coli was for bacteria, the GAL4 system of galactose 
metabolism in Saccharomyces cerevisiae has been a quintessential example of transcriptional 
activation and inhibition in eukaryotes. The GAL4 transcription factor binds to the upstream 
activating sequence (UAS) of key galactose metabolism genes and, in the presence of galactose, 




interaction of GAL4 with GAL11/MED15, which is part of the Mediator coactivator complex in 
eukaryotes that facilitates activation by forming a physical bridge between transcription factors 
bound to DNA regulatory elements and RNA polymerase II 147–151. Inhibition of GAL4 
activation occurs in the absence of galactose, when GAL4 becomes bound by a GAL80 152. 
Addition of galactose results in binding of GAL80 by GAL3, release of GAL4 by GAL80, and 
association of GAL4 with GAL11. GAL4 remains bound to the UAS regardless of galactose 
status 153,154. 
DNA binding of the GAL4 protein is specific to the GAL UAS, and both sequence and 
protein have only been found in yeast. The UAS of the GAL genes is comprised of four closely 
related 17 base pair sequences, the consensus of which is a palindromic. Synthetic versions of 
this sequence were created to maximize GAL4 binding, and single or multiple copies of these 
synthetic 17-mers were used to facilitate GAL4-dependent gene activation 146,155. Neither the 
GAL4 protein, nor the UAS sequence have any gene activating properties on their own; 
therefore, use of this system requires two components: a UAS upstream of a target gene of 
interest, and a separate Gal4 gene to encode the trans-activating protein 156. Because the 
Mediator complex is so tightly conserved in eukaryotes, an exogenous GAL4/UAS system is 
capable of activating transcription in other eukaryotic organisms 155,157–161.  
The use of the GAL4/UAS system became particularly popular in animal studies in 
which parental strains each carry one component of the bifurcated system, termed “driver” and 
“responder”, or “transactivator” and “target” depending on the organism 156,162. Brand and 
Perrimon showed the first example of this in Drosophila when they performed a series of 
experiments by inserting the gal4 gene into a P-element and driving responder gene expression 




transposition. They recapitulated embryonic gene expression patterns using a UAS-lacz 
responder, but were also able to “misexpress” the drosophila even-skipped gene in an 
embryonically inappropriate pattern, altering the fates of the affected cells, and explore the 
effects of a deleterious mutation of the Dras oncogene in a tissue-specific manner 163. One of the 
implications of this system they described was the ability to study gene products that are toxic or 
lethal in a stable, transgenic line because neither parental line would exhibit any deleterious 
effects, which was later shown with the targeted overexpression of the proto-oncogene int-2 in 
mice 162.  
Early studies using the GAL4/UAS system in zebrafish were focused on enhancer-trap 
studies to identify the mostly unmapped regulatory regions of the zebrafish genome, but later 
work focused on pairing the delicate structures of axons and dendrites of the zebrafish brain to 
the attached neurons, a process that was hindered by the ability to accurately stain these 
structures 164–166. Neural networking pathways of Drosophila were also examined using this 
system, with the added transcriptional control mechanism of a temperature-sensitive GAL80 
protein, which allows temperature-controlled deactivation of the GAL4 transactivator 167.  
As useful as the GAL4 protein has been as a transcriptional transactivator, perhaps the 
most useful property of the protein is the modular structure of its functional domains. One of the 
earliest studies of the GAL4-UAS system in Drosophila showed that the DNA-binding domain 
and the transactivating domains of the GAL4 protein function separately 157, which enabled 
researchers to switch the GAL4 activating domains with those from other proteins. The first 
exploration of this domain switching involved cloning random fragments of the E. coli genome 
onto the DNA-binding domain of GAL4 168. A few of these fusion proteins displayed modest 




clones, investigators produced a synthetic amphipathic alpha helix that acted as a transactivation 
domain 158,169. Encouraged by the success of these first fusion proteins, researchers selected a 
highly acidic fragment of the known herpes virus transcriptional activator VP16 to test for 
transactivation ability. The resulting Gal4-VP16 fusion protein stimulated activation of the 
reporter cat gene one hundred times more than the wild-type GAL4 protein in mammalian cells 
170. The GAL4-VP16 protein became the most popular transactivator for the induction of specific 
genes in mammalian cells and was only improved upon when a four-fold concatenation of the 
VP16 activating domain was created, called VP64 171,172.  
Other viral proteins were investigated for transcriptional transactivating activity as GAL4 
fusion proteins, including the adeno-associated virus protein E1A, and the Epstein-Barr virus 
protein Rta 173,174. However, the true strength of this system was to investigate the activity of 
endogenous proteins in a controlled setting. Because of the specificity of the GAL4 DNA-
binding domain, researchers were able to investigate the activity of cellular proteins like 
transcription factors when tethered to a specific locus 175,176. An early experiment with the tumor 
suppressor protein p53 demonstrated that the first 77 amino acids acted as a transcriptional 
activator when tethered upstream of a cat gene in mammalian cells 177. This sequence activated 
transcription to nearly the same levels at the GAL4-VP16 in the same experiment and was later 
found to include the domain responsible for contacting the TATA-binding associated factors of 
the general transcription factor TFIID 178.  GAL4 fusions of other transcriptional activators like 
the transcription factor p65 and the coactivator p300 were also created, both to activate desired 
genes and to characterize other proteins that inhibit these specific activators 171,179,180. Regulation 
of some transcriptional activators was achieved through co-transfection of GAL4-fusion proteins 




the regulatory effect of GAL80 on wild-type GAL4 181–185. Other transactivators were designed 
to respond to cellular signals, such as hormones or metabolites 186,187.  
This platform was not limited to the study of transcriptional activation, since the GAL4 
DNA-binding domain has no inherent effect on transcriptional output. Therefore, the GAL4 
platform was also a useful tool to investigate the behavior of transcriptional repressors when 
tethered to a reporter gene.  In an experiment initially designed to find binding partners for the 
subnuclear organelle protein SP100, researchers discovered that direct fusion of the GAL4 DNA-
binding domain with human HP1α drastically reduced expression of a cat reporter gene 188. 
Further studies with this structural component of heterochromatin demonstrated that Drosophila 
and mouse homologues of HP1 were also sufficient to induce gene silencing 189,190. One study 
looking at the specific human isoforms of HP1 suggested that HP1α and HP1γ were more 
efficient at inducing transcriptional silencing than HP1β and that the difference in repression was 
due to the inability of HP1β to impede the transcriptional activity of the hTAFII130 component 
of the general transcription factor TFIID 191. Another study found that GAL4-HP1 inactivation of 
a transiently-transfected reporter was contingent on the cellular expression of the DNA 
methyltransferase DNMT1 and that HP1γ was found at the active promoter of the endogenous 
Survivin gene, while HP1α and HP1β were bound to the same reporter after the gene was down-
regulated with doxorubicin 192. Other transcriptional repressors were studied in this manner in 
mice, fish and worms 193–195. One particular experiment led to the characterization of a putative 
histone methyltransferase, PRDM8, as a transcriptional repressor in mouse testes 196.  
These experiments describe the fusion of GAL4 binding domain with transcriptional 
effector proteins in order to characterize the activity of those effectors, but another function of 




experiment mentioned before. This function utilizes two fusion proteins and is referred to as a 
two-hybrid system. 
 
1.5. Yeast two-hybrid screening for protein-protein interactions 
 
The yeast two-hybrid system was designed in 1989 as a method for detecting protein-
protein interactions in a cellular environment. The system consists of two fusion proteins that 
each contain functional domains of the GAL4 transactivator. The first fusion protein contains the 
GAL4 DNA binding domain (BD) fused to a protein of interest, X, and remains bound to the 
GAL4 UAS upstream of a reporter gene. The second fusion protein consists of the GAL4 
transactivation domain (AD) and a second protein of interest, Y. If X and Y interact in the cell, 
then the AD will be localized to the BD and activate transcription of the gene 197. In the first 
example of this system, the yeast proteins SNF1 and SNF4 were chosen for the proteins of 
interest because it was previously known that these proteins were physically associated in the 
cell. Neither of the fusion proteins, BD fused to SNF1, or AD fused to SNF4, were capable of 
singly inducing transcription of the lacz reporter gene. It was only when both fusion proteins 
were present that transactivation of the reporter gene occurred, albeit to a lower degree than that 
induced by the native GAL4 protein.  
Though this is an excellent system to verify the interaction of two known proteins 198–201, 
it was quickly modified into a screening assay to identify novel protein binding partners. The 
screen involves a known protein fused to the GAL4 BD as the “bait”, and an unknown protein 
fused to the GAL4 AD as the “prey.” If the prey protein interacts with the bait protein, it results 
in transactivation of a reporter gene. The first such screen used SIR4, a protein involved in 
transcriptional repression of the yeast mating-type locus, as bait. A screening library of potential 




individual DNA fragments from the yeast genome 202. The plasmids were transformed into a 
yeast strain that was a mutant for gal4, gal80, and the genes required to synthesize the amino 
acids histidine and leucine 203. The bait and prey plasmids each contained a selectable marker, 
enabling yeast transformants with both plasmids to grow on a medium lacking histidine and 
leucine. Approximately 1 in 14,000 yeast colonies expressed blue color when plated on X-gal, 
indicating expression of the lacz reporter gene. After eliminating prey plasmids that enabled 
transactivation of the reporter gene without interaction with the bait protein, such as the yeast 
wild-type gal4 gene, two genes were identified that produced binding partners of SIR4. Because 
of this ability for unknown proteins to transactivate gene expression independently, the authors 
caution that the unknown, screened proteins must always be cloned on the prey plasmid 202. 
Improvements upon this initial screening platform were engineered to make the process 
more high-throughput and improve the 1 in 14,000 ratio. In one technique, a second reporter 
gene was introduced that was also under GAL4-UAS regulation and contained a third selectable 
marker. In this system, only transformants that contained both bait and prey plasmids and 
initiated GAL4 transactivation would survive nutrient selection 204. Another technique employed 
the use of yeast mating types to perform a protein-binding screen. Instead of transforming both 
bait and prey plasmids into a single cell, individual plasmids were transformed into haploid yeast 
strains that were genetically identical except for mating type. When these two haploid strains 
were mated together, the resulting diploid strain contained both bait and prey plasmids and could 
be screened for GAL4 transactivation. This system had two advantages: the mating of haploid 
yeast strains was more efficient than co-transformation of two plasmids into a single cell, and the 




Researchers also progressed from using DNA libraries 206 to cDNA libraries 207, which 
not only provided a more native protein structure but also allowed the interrogation of proteins 
from organisms with much larger genomes, such as Drosophila, mouse, human, and Arabidopsis  
208–211.  Using mouse cDNA in a yeast two-hybrid screen, researchers identified an interaction 
between DNMT3A and the centromeric protein CENP-C, two important proteins for centromere 
stability 212, and the endosomal cysteine proteases cathepsin B and cathepsin L with the viral 
capsid proteins of Adeno-associated Virus (AAV) 2 and 8, providing much needed information 
about the process of AAV viral transduction 213. However, people soon exported this two-hybrid 
system out of yeast, and migration of this two-hybrid system to other organisms involved 
exchanging some of the core components. Use in mammalian cells often involved exchanging 
the GAL4 AD with that from VP16, the GAL4 BD with the E. coli DNA-binding protein LexA, 
or the lacz reporter gene with cat or gfp 198,214–218. Some of these modular substitutions were 
imported back into the yeast two-hybrid system, and some were used for screening in Drosophila 
and Arabidopsis 208,209,211,219–221. Eventually, two-hybrid systems evolved that no longer 
contained any of the original GAL4 components, like a system in yeast using the LexA DNA-
binding domain and the VP16 transcriptional activator that identified a new family of basic 
helix-loop-helix transcription factors from mouse embryo cDNA 222. 
Variations on the two-hybrid system abound, including third protein interaction 
experiments, “reverse” two-hybrid screens, and small-molecule-based protein hybrid systems. In 
third protein experiments, interaction between the two hybrid proteins only occurs in the 
presence or absence of a third protein. An example of this interaction was performed with cyclin 
dependent kinase (CDK)-activating complex (CAK): the complex subunits CDK7 and ménage a 




transcription of a reporter gene when a third subunit, cyclin H, was also expressed in the cell. In 
the same report, it was shown that interaction between the GAL4-fusion products of two proto-
oncogenes, H-Ras and cRaf-1, could be interrupted by expression of an unbound cRaf-1, in a 
cellular example of a competition experiment 223.  In reverse two-hybrid screens, the goal is to 
identify mutations in proteins that stop the interaction of two protein binding partners and result 
in silencing of the reporter gene. In these screens, reporter genes are often genes that create toxic 
gene products when activated or genes that create negative regulators of transcription, like the 
Tet repressor, and prevent a strain of yeast from growing on a particular medium 224. One such 
study identified a mutation in the apoptosis-signaling Fas Associated Via Death Domain (FADD) 
protein which abolished protein interaction with one known biding partner but not another 225. 
Small-molecule-based protein hybrid systems include the addition of a small molecule to inhibit 
or facilitate the binding of two fusion proteins. This type of two-hybrid screen was used to find 
small-molecule inhibitors of the H-Ras/Raf-1 interaction in mammalian cells 226 and between 
two different subunits of the same N-type calcium channel protein 227.  Small molecules were 
also designed to force the heterodimerization of proteins that did not naturally interact 228. 
This chemically-induced proximity (CIP) of two fusion proteins is the crux of the Chromatin in 
vivo Assay, a tool for inducing and monitoring changes in the chromatin landscape of a targeted 
locus. 
 
1.6. The Chromatin in vivo Assay 
 
The FK506-binding protein FKBP-12 is a cytosolic protein involved in protein-folding 
and chaperoning and is a pharmacological target for the immunosuppressant small-molecules 




(mTOR), also known as FK506-binding protein 12-rapamycin-associated protein 1 (FRAP1), 
binds to the FKBP-12-rapamycin complex with high affinity 231. This affinity is mediated by the 
FK506-rapamycin binding-domain (FRB) of mTOR/FRAP1. In a study using FKBP-12 fused to 
the GAL4 BD and FRB fused to GAL4 AD, researchers were able to induce expression of a 
reporter gene in a rapamycin-dependent manner in yeast 232. In a similar experiment in 
mammalian cells, FRB was fused to the p65 activating domain, and FK506-12 was fused to the 
DNA binding domain of ZFHD1, a transcription factor from Arabidopsis that binds to a plant-
specific DNA sequence 231,233.  In both studies, dimerization of the fusion proteins and activation 
of the reporter gene only occurred in the presence of rapamycin. Because FKBP-12 also binds to 
the small-molecule FK506, addition of FK506 can antagonize the dimerization by competitive 
inhibition.  
It was from these fundamental building blocks that Hathaway et al. created the 
Chromatin in vivo Assay (CiA) 234. The CiA was a tool developed to induce changes in the 
chromatin architecture of an endogenous gene in a chemically-dependent, reversible manner. 
The GAL4-UAS and ZFHD1- binding-sequence were inserted upstream of the Oct4 promoter in 
mouse embryonic stem cells, and the first exon of the Oct4 gene was replaced with a gene 
encoding nuclear EGFP. Using GAL4 BD fused to FKBP-12 and FRB fused to the 
chromoshadow of mammalian HP1α (csHP1α), they succeeded in silencing gene expression of 
the Oct4-gfp reporter through the addition of rapamycin. This gene repression was accompanied 
by changes in histone posttranslational modifications that spanned kilobases from the GAL4-
UAS. An increase in H3K9me3 and endogenous HP1γ at the locus was concurrent with a loss of 
the positive markers of gene expression, such as trimethylation of lysine 4 on histone H3 




quantitative polymerase chain reaction (qPCR).  Reversal of the CIP and removal of the tethered 
csHP1α was achieved by removal of rapamycin and addition of FK506.  
Using this system, Hathaway et al. observed how an induced heterochromatin domain 
behaved after removal of the ectopic stimulus of CIP and were able to develop a mathematical 
model for the maintenance of such a domain based on the propagation and loss of the H3K9me3 
mark. Expansion of this assay into mouse embryo fibroblasts (MEFs) allowed for identification 
of cell-type specific factors that contributed to heterochromatin maintenance after multiple cell 
divisions, and the presence of two DNA binding arrays allowed for simultaneous recruitment of 
two different sets of fusion proteins to the locus 234. The CiA system has been used in subsequent 
studies to validate or screen for novel compounds that interrupt heterochromatin formation 
induced by HP1 proteins 235–237  and to screen for molecules that increase reactivation of Oct4 in 
differentiated cells 238.  
Here, I report the construction of a modified Chromatin in vivo Assay that is modular and 
self-contained with interchangeable promoter, reporter gene, and CRISPR/Cas9-compatible 
homology arms. I used this next-generation CiA to characterize and compare the gene-silencing 
capacity of the human silencing hub (HUSH) complex subunit m-phase phosphoprotein 8 
(MPP8) to the mammalian HP1 isoforms and to elucidate through comparison the importance of 
promoter structure on the maintenance of an induced heterochromatin domain. This assay will 
serve as yet another tool with which researchers can explore and contort the chromatin landscape 
in order to learn more about the suite of proteins that control the expression and repression of 
transcription through histone post-translational modifications, nucleosome positioning, or 





Table 1.1. Chromatin related proteins identified as suppressors of variegation. Data obtained from Flybase.org, FB2019_03, 
released Jun 11, 2019 
 
Symbol UniProt Function 
H. sapiens M. musculus S. cerevisiae 
orthologs orthologs orthologs 
AGO2 Essential for RNA interference (RNAi). 
AGO3 , AGO1 , AGO4 , 
PIWIL2 , AGO2 , PIWIL3 , 
PIWIL1 , PIWIL4 
Piwil2 , Ago4 , Piwil4 , Ago2 , 
Piwil1 , Ago3 , Ago1 CUR1 , BTN2 
ash1 Trithorax group (TrxG) protein  
SETD2 , SETBP1 , DIDO1 , 
NSD2 , NSD1 , SETD1A , 
SETD5 , KMT2C , PHF20L1 
, KMT2D , ASH1L , KMT2E 
, NSD3 , SETD1B , PHF20 
Setd5 , Spocd1 , Kmt2e , 
Phf20l1 , Setbp1 , Setd1b , 
Nsd1 , Phf3 , Kmt2c , Nsd3 , 
Setd1a , Ash1l , Nsd2 , Setd2 , 
Dido1 , Kmt2d 
CTI6 , BYE1 , 
SET3 , SET4 , 
SET1 , RSC2 , 
SET2 
aub 
Acts via the piwi-interacting 
RNA (piRNA) metabolic 
process  
AGO4 , PIWIL2 , AGO2 , 
PIWIL3 , PIWIL1 , PIWIL4 , 
AGO1 , AGO3 
Piwil4 , Ago2 , Ago4 , Piwil2 , 
Piwil1 , Ago1 - 
Dcr-1 Essential for RNA interference (RNAi). DICER1 , FANCM , DHX58 Dhx58 , Fancm , Dicer1 MPH1 , IRC3 
E(z) Polycomb group (PcG) protein  SETD7 , EZH2 , EZH1 Ezh2 , Setd7 , Ezh1 SET2 
egg Histone methyltransferase that  SETDB2 , SETDB1 Setdb1 , Setdb2 SET2 
gpp Histone methyltransferase.  DOT1L Dot1l DOT1 
HDAC1 
Catalyzes the deacetylation 
of lysine residues on the N-
terminal part of the core 
histones (H2A, H2B, H3 
and H4). 
HDAC3 , HDAC1 , HDAC2 , 
HDAC8 Hdac2 , Hdac1 , Hdac3 , Hdac8 
RPD3 , HOS1 , 
HOS2 




Kdm4A Probable histone demethylase  
KDM4D , KDM4A , KDM4E 
, KDM4C , KDM4B 
Kdm4a , Kdm4c , Kdm4b , 
Kdm4d GIS1 , RPH1 
Kdm4B Probable histone demethylase  
KDM4C , KDM4D , KDM4E 
, KDM4B , KDM4A 
Kdm4a , Kdm4d , Kdm4b , 
Kdm4c GIS1 , RPH1 
MRG15 
Part of the Tip60 
chromatin-remodeling 
complex.  
MORF4L2 , ARID4A , 
ARID4B , MSL3 , MORF4L1 
Msl3l2 , Gm5073 , Arid4a , 
Morf4l2 , Morf4l1 , Arid4b , 
Msl3 , Morf4l1b 
EAF3 
Pc Polycomb group (PcG) protein.  
CBX2 , CBX6 , CBX8 , 
CBX7 , CBX4 
Cbx7 , Npcd , Cbx2 , Cbx4 , 
Cbx6 , Cbx8 - 
PCNA Auxiliary protein of DNA polymerase delta  PCNA Pcna POL30 
ph-p Polycomb group (PcG) protein.  
SAMD11 , PHC1 , SAMD13 
, SAMD7 , PHC3 , SCML2 , 
PHC2 , SAMD1 , M6PR 
Phc1 , Samd11 , Phc3 , Samd1 , 
Phc2 , Samd7 - 
PR-Set7 Histone methyltransferase   KMT5A Kmt5a - 
Sce E3 ubiquitin-protein ligase.  PCGF3 , RING1 , RNF2 , BRCA1 
Brca1 , Pcgf3 , Traip , Ring1 , 
Rnf2 - 
Sirt1 NAD-dependent histone deacetylase  SIRT1 , SIRT3 , SIRT5 Sirt3 , Sirt5 , Sirt2 , Sirt1 
HST4 , SIR2 , 
HST3 , HST2 , 
HST1 
Su(var)205 Structural component of heterochromatin 
CDY1 , CBX5 , CDY2A , 
CDY1B , CDYL , CBX3 , 
CDY2B , CDYL2 , 
MPHOSPH8 , CBX1 , CBX7 
Cbx7 , Cbx5 , Cdyl2 , Cbx3 , 
Mphosph8 , Cdyl , Cbx1 NEW1 
Su(var)3-3 Probable histone demethylase  
SMOX , MAOB , KDM1B , 
PAOX , KDM1A , MAOA 
Maob , Maoa , Kdm1b , Paox , 
Kdm1a , Smox FMS1 
Su(var)3-9 Histone methyltransferase  
PRSS48 , SUV39H1 , 
EHMT1 , SETMAR , 
EHMT2 , SUV39H2 
Suv39h1 , Eif2s3x , Tpsb2 , 
Setmar , Suv39h2 , Ehmt2 , 
Ehmt1 
GCD11 , SET2 









trx Histone methyltransferase   PHF11 , KMT2A , KMT2B , PHF7 
Phf11a , Phf11c , Gm6904 , 
Kmt2a , Phf11b , Phf11d , 
Kmt2b , Phf7 
SET1 
XNP 
Modifies gene expression 
by affecting chromatin 
(Potential). 
DNMT3B , RAD54L2 , 
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CHAPTER 2: Creation of a new modular Chromatin in vivo Assay 
2.1. Introduction 
Transcriptional regulation of gene expression occurs at both the level of the DNA 
sequence, with DNA-binding proteins and DNA methylation, and at the level of the nucleosome, 
with histone post-translational modifications and nucleosome remodelers 1. Early studies of the 
control of eukaryotic gene expression were based upon the GAL4 transactivator from yeast. This 
protein binds to sequences upstream of the galactose-responsive genes is Saccharomyces 
cerevisiae and regulates transcription of these genes through interaction with the Mediator 
complex of coactivators 2,3. Researchers uncoupled the DNA-binding and transcriptional 
activating domains of GAL4 in order to characterize other proteins that could activate or 
suppress gene expression when fused to the GAL4 DNA-binding domain. Most of these proteins 
fell into the category of DNA-associated proteins and included transcription factors or proteins 
that interact with transcription factors 4–7.  One of the first nucleosome-associated proteins to be 
surveyed in this manner was heterochromatin protein 1 (HP1), and it was demonstrated that 
direct tethering of different isoforms of HP1 to a reporter gene resulted transcriptional silencing 
8,9. HP1 at this time was known to be a non-histone protein associated with heterochromatin and 
whose mutation resulted in suppression of variegation, but it was not yet known that HP1 
interacted with nucleosome-modifying enzymes such as the histone methyltransferases 
Suv39h1/2 or SETDB1 10–13. Therefore, it was proposed that the gene-silencing ability of HP1 




Hathaway et al. harnessed mammalian isoform HP1α in the Chromatin in vivo Assay 
(CiA) they demonstrated that the silencing capabilities of HP1α instead relied upon its ability to 
transform the surrounding chromatin environment from one of open euchromatin to one of 
closed heterochromatin 14. This transformation included the alteration of histone posttranslational 
modifications that spread ten kilobases from the effected locus. The CiA is a technology that 
uses fusion proteins to reversibly tether a chromatin modifying protein to a gene of interest, 
using a small molecule for chemically-induced proximity. In the first generation of the CiA, 
effector proteins were recruited to the Oct4 allele in mouse embryonic stem (ES) cells. This 
allowed for the for the characterization of HP1α-induced gene silencing and heterochromatin 
formation at the Oct4 allele. However, the Oct4 gene is a master pluripotency regulator and as 
such is very highly expressed in ES cells and very tightly repressed in differentiated cells 15,16. 
Thus, it was an inappropriate tool to examine the gene-silencing capabilities of effector proteins 
that were less efficient than HP1α (unpublished data). In the second generation CiA (CiA 2.0), 
we designed an assay that would be less regulated by the underlying transcriptional program of 
the cell and thus allow the examination of subtler chromatin effectors. 
Another protein that has more recently been associated with heterochromatin is MPP8. 
MPP8 is one third of the core human silencing hub (HUSH) complex, along with TASOR and 
periphilin 17. Like HP1, the N-terminal chromodomain of MPP8 can bind H3K9me2/3 and can 
recruit the histone methyltransferase SETDB1 and the DNA methyltransferase DNMT3A 17–20. 
Rather than the centromere and telomeres, MPP8 is typically found at sites of KRAB-ZF genes, 
as well as at the sites of new transposon and retrovirus insertions17,21. In fact, MPP8 and TASOR 
are both targeted for degradation by HIV-2/ SIV viral protein X, making it an attractive target to 




cancers and is required for silencing of the tumor suppressor gene E-cadherin in HEK293 and 
prostate cancer cells, as well as the silencing of HOXa5 in non-small cell lung cancer 23,24. It has 
also been implicated in Charcot-Marie-Tooth disease through an interaction with the ATP-
dependent chromatin remodeler MORC2 25.  
Using CiA 2.0, we document the ability of MPP8 to induce transcriptional silencing of a 
gene and compare the silencing efficiency of MPP8 to all three mammalian isoforms of HP1. We 
found that gene silencing by MPP8 does not proceed as quickly, or as completely, as that 
conferred by HP1. We also found that reactivation of transcription of the reporter gene after 
silencing with MPP8 results in a rebound transcriptional response that results in gene expression 
almost twice as high as before the induction of silencing. This rebound response is not seen with 
HP1-induced silencing, and suggests that there are fundamental differences the mechanism of 
gene silencing of these two proteins. Further studies are required to determine if MPP8 can 
induce a heterochromatin domain, and how that domain differs from that produced by HP1. 
2.2. Methods: These methods are adapted from those reported in “Contribution of promoter DNA 
sequence to heterochromatin formation velocity and memory of gene repression in mouse 
embryo fibroblasts” PLOS ONE 14(7): e0217699 
Plasmid design and generation: The CMV/Ef1α promoter was stitched together by PCR 
using primers in Table 2.1. The CiA expression plasmid was created by inserting the promoter into 
the BamHI site of a reporter with ZFHD1 and Gal4 DNA binding domains upstream of a minimal 
IL2 promoter and nucEGFP (N261), using infusion cloning (Clontech). Balb/C-specific homology 
arms were amplified from genomic DNA of TC1 mouse ES cells. The HP1-tandem-FRB 
expression plasmids were generated by removing the chromoshadow of HP1α (csHP1α) from a 
preexisting csHP1α-tandem-FRB expression plasmid (N163 26 Addgene #44195) and replacing it 




insertion of MPP8 into an existing FRB-containing plasmid (0111), and replacing the blasticidin 
resistance gene with puromycin. The Cas9 and sgRNA containing plasmid (P023) was created as 
described 27. All cloning steps were performed in DH5α or One Shot Stbl3 cells (Invitrogen). 
Cell culture and CIP silencing assay: Transformed MEFs were produced as described 28. 
Cells were grown in FBS-supplemented growth media (Gibco 26140-079, Lot #1972526) 29 and 
selected with 9 µg/ml blasticidin and 6.5 µg/ml puromycin to drive lentivral insertions of the 
GAL4-FKBP and FRB-HP1 or FRB-MPP8 plasmids. One day prior to experimentation, 
blasticidin and puromycin were removed from the cells, which were then grown in drug free media. 
Rapamycin from a 10 µM stock dissolved in ethanol was added to media at 3 nM concentration.  
Rapamycin washout: Washout of rapamycin was performed by the addition of FK506 at 
100 nM concentration for 48 hours, which competes with rapamycin at the active site of the FK506 
binding protein (FKBP). After 48 hours, cells were grown in drug-free media.  
CRISPR/Cas9 insertion of expression constructs: Cell lines were created using the Cas9 
double nuclease, as described 27. 2.5 µg of the Cas9 expression plasmid (P023) and 2.5 µg of the 
CiA expression plasmid (linearized with KpnI) were co-transfected into one million transformed 
MEFs using an Amaxa 4-D Nucleofector on program EH-100. 
Lentiviral infections: 293T LentiX cells (Clontech) were transfected using 
polyethyleneimine (PEI), as described in 30. Lentiviral infection of the clonal lines with the FRB 
and GAL4-FKBP fusion proteins required an outgrowth time of two days before selection with 
blasticidin (N118, Addgene #44245) or puromycin (P072, P073, P076, C008). Lentiviral infection 
of the GAL4-HP1α direct fusion protein (N111) and the GAL4 only protein (N113) required an 
outgrowth of two days before selection with puromycin, and were passaged for 14 days after 




PCR verification of inserts: Isolation of clonal lines was described previously. Genomic 
DNA was isolated from each line using a previously described method 26. Cells were digested with 
Proteinase K at 400 µg/ml at 56 °C overnight, then purified by phenol/chloroform extraction and 
ethanol precipitation. PCR verification of proper insertion was performed with a primer inside the 
nucEGFP of the expression construct and a primer outside of the 5’ homology arm. PCR 
identification of Cas9 insertion was performed with primers located inside the Cas9 gene.  
Flow cytometry: The flow cytometry was performed in the UNC Flow Cytometry Core 
on an iQue Screener PLUS (IntelliCyt) or on an Attune Nxt (Thermo Fisher) in biological 
triplicate. Due to the differences in blue laser intensity, mean fluorescent intensity of GFP 
expression cannot be directly compared between the two machines. The laser settings used for 
the Attune in Figure 2.2 were not the same used in Figures 2.3 and 2.4. Samples were analyzed 
using FlowJo software. 
 
2.3. Results 
The CiA is relies on fusion proteins that dimerize in the presence of the small molecule 
rapamycin (Fig 2.1A). The first fusion protein consists of a DNA binding domain, either the 
Gal4 DNA-binding domain (GAL4) or the ZFHD1 DNA binding domain, fused to FKBP. This 
fusion protein remains bound to the corresponding DNA binding sequence upstream of a reporter 
gene. The second fusion protein consists of two copies of the FK506 rapamycin-binding domain 
(FRB) fused to an effector protein of interest. The FKBP and the FRB domains come into 
contact only in the presence of rapamycin, effectively tethering the effector protein to the 
reporter gene in a chemically-dependent manner. The effector protein can then activate or repress 




system will uncouple the fusion proteins, reversing the artificial tether and leaving the induced 
transcriptional program to the endogenous cellular machinery. 
The creation of the first-generation CiA relied on the cellular process of homologous 
recombination in mouse ES cells to insert these DNA sequences into the mouse genome. Using 
multi-kilobase homology arms, Gal4 and ZFHD1 DNA binding arrays were inserted downstream 
from an endogenous Oct4 promoter, and a reporter EGFP gene replaced the first exon of the 
Oct4 allele. This specificity of insertion was possible because mouse ES cells are particularly 
amenable to homologous recombination 14. In creating the second generation CiA (CiA 2.0), we 
used the genome editing technology CRISPR/Cas9 to edit the genome in Large-T transformed 
mouse embryo fibroblasts (MEFs).  CiA 2.0 is modular and contains an exogenous promoter 
upstream of the DNA binding arrays and reporter gene (Fig 2.1B). For this iteration of our 
expression cassette, we used a CMV enhancer with a core EF1α promoter and a gene encoding 
nuclear EGFP with an SV40 polyA tail. The first arrangement of this cassette did not express 
EGFP efficiently in HEK293 cells, so we added a “spacer” region between the DNA binding 
arrays and the nucEGFP that consists of sequence from a minimal IL2 promoter that alone was 
not sufficient to drive expression from stable MEF cell lines (data not shown).  This expression 
cassette is flanked by homology arms of only 800 bp each, and each component of this 
expression cassette is exchangeable on plasmid due to strategic restriction enzyme cut sites. This 
allows for easy comparison of multiple promoters, reporter genes, or genomic insertion sites with 
relative ease.  
The smaller homology arms needed for CRISPR/Cas9 technology means that a round of 
relatively simple PCR allows for the insertion of the expression cassette anywhere in the genome 




line with a CiA construct at an intergenic region downstream from the embryonic hemoglobin 
locus in mouse embryo fibroblasts. This region of the genome is controlled by the beta globin 
locus control region (LCR), which tightly regulates which of the globin genes are expressed, 
depending on the timing of mouse development 31. This region has long been of interest for 
transgene expression profiling and heterochromatinization studies, because of the potential for 
control of globin switching for the treatment of beta thalassemia or sickle cell diseases 32,33. We 
determined successful CRISPR insertion of our construct in clonal MEF lines using PCR (Fig 
2.1C). However, puromycin resistance in some of these clonal lines pointed to stable integration 
of the Cas9 expression plasmid. Subsequent PCR for the Cas9 gene confirmed Cas9 plasmid 
insertion in most of the clonal lines (Fig 2.1D). In fact, off-target effects from the CRISPR/Cas9 
technology resulted in insertions of the CiA cassette in multiple locations in the mouse genome, 
reported elsewhere 28.  
Because we were uncertain if these multiple genomic insertions would refract any 
silencing of our reporter gene, we chose a clonal line that did not have the Cas9/puromycin 
integration, shown with an asterisk in Figure 2.1D, and infected it with the direct fusion protein 
GAL4-HP1α. This GAL4-HP1α was indeed successful in silencing nucEGFP gene expression in 
this cell line as measured by flow cytometry analysis of cellular fluorescence (Supplemental 
Figure 2.S1). Importantly, the GAL4 DNA binding domain alone did not have any effect on 
transcription. We therefore decided that this cell line was appropriate to use for our purposes.   
We next used this cell line to compare the silencing dynamics of the three mammalian 
HP1 isoforms: HP1α, -β and -γ. The three HP1 isoforms share more than 63% amino acid 
sequence identity (Fig 2.2A) 34. The proteins consist of an N-terminal chromodomain, a hinge 




the three isoforms, and is likely responsible for localizing HP1 to DNA 35. We sewed two FRB 
domains to the C-terminus of each HP1 isoform for recruitment in the CiA, and then induced 
HP1 recruitment to the CiA cassette by the addition of rapamycin. We demonstrated that HP1β 
was an efficient inducer of gene silencing, despite previous reports to the contrary (Fig 2.2C) 36. 
In fact, we show that all three mammalian isoforms induce silencing with the same efficiency, 
with a measureable change in gene expression merely 12 hours after CIP (Fig 2.2D).  
We then sought to determine if CIP recruitment of MPP8 was capable of inducing gene 
silencing. The MPP8 protein contains an N-terminal chromodomain, and C-terminal ankyrin 
repeats, but much of the 860 amino acid protein does not contain known protein domains (Fig 
2.3A) 37. We attached two FRB domains to the N-terminal chromodomain and recruited the 
protein with CIP. We show that MPP8 is sufficient to induce gene silencing in this cell line (Fig 
2.3B).  However, the time required for MPP8 to measurably reduce gene expression is almost 
double that of the HP1 isoforms (Fig 2.2D). In fact, complete silencing of the reporter gene does 
not occur even after six continuous days of MPP8 recruitment (Fig 2.3C). Whether or not 
transcriptional repression by MPP8 reflects the formation of an underlying heterochromatin 
domain remains to be seen.  
In order to determine if the CiA expression cassettes would regain transcriptional 
expression once each of the effector proteins was untethered, we induced CIP with rapamycin for 
six consecutive days then uncoupled the fusion proteins with the addition of FK506. The FKBP 
will bind FK506, displacing the FRB and reversing the chemical tether. We saw that the HP1 
isoforms returned to baseline expression within six days of chemical washout (Fig 2.4A). This is 




nucEGFP production of the cells silenced with MPP8 far exceeded baseline expression of the 
cell line before silencing (Fig 2.4B). 
2.4. Discussion 
This work demonstrates the ability of the CiA 2.0 to detect the influence of effector 
proteins that were insufficient to alter transcription at Oct4. We have shown that recruitment of 
MPP8 is sufficient to induce gene silencing in this system, and that its gene silencing properties 
differ from those of HP1. While all of the HP1 isoforms induced near total gene silencing within 
48 hours of recruitment, MPP8 effected silencing at a slower rate and did not cause complete 
silencing even after six full days of recruitment.  We also show that recovery from this induced 
silencing differs between HP1 and MPP8. HP1-silenced cells return to baseline after six days of 
chemical washout, and cells silenced with MPP8 express GFP at higher levels than they did 
before silencing. 
We have yet to discover if these differences in gene expression reflect differences in the 
underlying chromatin induced by the recruited protein. We have previously shown that 
recruitment of HP1 induces a heterochromatin domain characterized by H3K9me3 14,28. The next 
natural step in this line of inquiry is to determine whether recruitment of MPP8 induces changes 
of the chromatin environment of the CiA cassette. Given the size differences between the 185 
amino acid HP1 and the 860 amino acid MPP8, it is possible that MPP8 recruitment merely 
downregulates gene expression through steric hindrance of the transcriptional machinery. Two 
mutants are known to disrupt the binding of MPP8 to other proteins: the W80A mutation in the 
aromatic cage of the chromodomain disrupts binding of MPP8 to H3K9me3 or the methylated 
form of the histone methyltransferase GLP 19,20, and the Δ112-263 deletion mutant disrupts 
binding to the histone deacetylase SIRT1 38. Recruitment of either of these mutants, or a double 




steric interference overmuch. It is also possible that MPP8 actively induces gene silencing 
without changing the chromatin domain of the CiA locus. MPP8 is recruited to the silenced E 
cadherin gene through binding of its chromodomain to H3K9me3, and in turn recruits the DNA 
methyltransferase DNMT3A. Knockdown of MPP8 results in re-expression of the gene due to 
loss of DNMT3A localization, and not through a changes in posttranslational histone 
modifications at the gene 20.  
If MPP8 does induce a heterochromatin domain, there are many avenues through which it 
could be created. MPP8 has been found to bind SETDB1, GLP, DNMT3A, and Ring1 of the 
PRC1 complex 17,20,39. Therefore, the induced heterochromatin domain could potentially consist 
of several different histone posttranslational modifications, including H3K9me2, H3K9me3 or 
H3K27me3 40–42.  Given that we do not yet know if MPP8 recruits any previously known binding 
partners in the context of this assay, including the other components of the HUSH complex 
TASOR and periphilin, it is impossible to speculate what kind of domain is created, if any.  
 The most interesting of our findings using this assay were the incomplete gene 
repression and elastic gene reactivation of the CiA cassette in response to MPP8 recruitment. It 
will be important to determine if there is a fundamental difference between the cells that are 
silenced after six days of MPP8 recruitment, and those that are still exhibiting low gene 
expression. It is possible that the cells that are still expressing GFP are in a “poised” state 
regulation, characterized by both activating, H3K4me3, and repressive, H3K27me3, histone 
post-translational modifications. These poised chromatin states are usually found at the 
promoters of lineage specific genes in undifferentiated stem cells. Upon differentiation, 
promoters of tissue specific genes are released from this holding pattern, and rapidly commence 




examples of bivalent chromatin domains in more differentiate cell types. One study found both 
H3K4me3 and H3K9me3 on either side of the transcription start site of the master adipogenic 
genes Cebpa and Pparg in mesenchymal stem cells and preadipocytes. These genes were 
expressing at very low levels, and were bound by both paused RNA polymerase II, and SETDB1 
44. Another novel bivalent domain, consisting of H3K9me3 and H3K36me2/3, was found at the 
site of weakly expressing genes in HepG2 cells 45.  If recruitment of MPP8 in our system results 
in a bivalent chromatin domain, as opposed to a heterochromatin domain, it could explain the 
low levels of expression and quick reactivation of gene expression from our cassette. 
Fluorescence-activated cell sorting will reveal whether the cells that are still weakly expressing 
after six days of MPP8 recruitment are the same cells that hyper-activate gene expression after 
CIP release.  
Despite the unexpected and off-target genomic insertions of our CiA cassette, we have 
established its utility in characterizing the activity of disparate chromatin effectors. We have 
demonstrated the identical gene-silencing ability of all three mammalian HP1 isoforms, as well 
as characterized the repressive power of the more recently characterized MPP8. This assay will 
continue to be an excellent tool to characterize the gene-silencing properties of proteins like 






Table 2.1 Primers used in construction of plasmids and for detection of genomic insertions 




Inside reverse sewing primer 
to create CMV/Ef1α 





Inside forward sewing primer 
to create CMV/Ef1α 





Outside reverse sewing 
primer to create CMV/Ef1α 




Oligo to create sgRNA and 
anneal into CRISPR delivery 
plasmid 
sgRNA PV002 AAACTTTCAGTTCAGAG
CAGACAC    
Oligo to create sgRNA and 




Primer inside of nucEGFP to 





Forward primer to amplify 
Balb/C homology arm 2 for 




Reverse primer to amplify 
Balb/C homology arm 2 for 




Forward primer to amplify 
Balb/C homology arm 2 for 




Reverse primer to amplify 
Balb/C homology arm 2 for 
infusion into plasmid 
PVP185 TGCACATCAGTATGGCT
TTTGAGGC 
Primer upstream of 5’ 
homology sequence to 




Forward primer in Cas9 gene 
PVP266 GATGGGCTTATCCCGGT
GCT 








Forward primer for MPP8 





Reverse primer for MPP8 





Outside forward primer to 




Inside reverse primer to insert 




Inside forward primer to 





Outside forward primer to 
insert HP1x-FRB into N103 





Outside forward primer to 




Inside reverse primer to insert 




Inside forward primer to 





Outside reverse primer to 








Figure 2.1. The CiA 2.0 is a modular tool for transcriptional control by effector proteins. 
A) Two fusion proteins are brought into close proximity by the addition of rapamycin, tethering 
an effector protein to a DNA-binding domain upstream of a nucEGFP reporter gene and inducing 
a change in gene expression. B) The CiA reporter cassette is modular, with restriction sites 
between components to make homology arms, promoter and reporter genes exchangeable on 
plasmid. C) Successful integration of the CiA cassette into clonal cell lines as confirmed by 
PCR. Arrow designates correct band. Asterisk designates clonal line used in this study. D) 
Random integration of the Cas9 expression plasmid into genomic DNA confirmed by PCR. 







Figure 2.2. The three mammalian HP1 isoforms silence gene expression with equal 
efficiency. A) Clustal-ω alignment of the three mammalian isoforms of HP1, with percent 
identity matrix. Chromodomains are denoted in purple, chromoshadow domains are denoted in 
pink. B) Diagram of a full-length HP1 protein repressing gene expression in the CiA. C) 
Recruitment of HP1β silences gene expression of the CiA cassette. D) All three isoforms of HP1 





Figure 2.3. Recruitment of MPP8 represses transcription in the CiA. A) Diagram of the 
MPP8 protein tethered to the CiA cassette by CIA. B) Recruitment of MPP8 suppresses 
transcription from the reporter cassette over three days. C) Comparison of gene repression 








Figure 2.4. Recovery of gene expression after silencing differs between HP1 and MPP8. A) 
Cells repressed by the HP1 isoforms regain baseline gene expression after six days of release 
from CIP. Baseline expression is denoted by horizontal dotted lines. B) Cells repressed by MPP8 
surpass baseline gene expression after six days of release from CIP. Baseline expression is 
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Figure 2.S1. Direct HP1α-GAL4 fusion protein suppresses transcription from the CiA 
cassette. HP1α fused to the DNA-binding domain of GAL4 suppresses transcription from the 



















CHAPTER 3: Contribution of promoter DNA sequence to heterochromatin formation 
velocity and memory of gene repression in mouse embryo fibroblasts 
3.1. Introduction 
The mammalian genomic landscape can be broadly divided into two regions defined by 
chromatin accessibility and a number of epigenetic marks. Active genes reside in a more open 
and accessible euchromatin compartment, allowing for facile transcription factor binding and 
transcription of RNA, while inactive genes are typically found in condensed heterochromatin. 
Gene expression programs, which are carefully maintained through selective gene repression by 
heterochromatin pathways, are carefully timed during development and then faithfully preserved 
in defined tissues. Multiple distinct epigenetic pathways are in place to ensure that 
heterochromatinized regions of the genome remain transcriptionally silenced after successive 
rounds of cell division. The heterochromatin protein-1 (HP1) pathway relies on a feedforward 
method of propagation, where the chromodomain of HP1 binds a histone H3 tri- or di-
methylated lysine (H3K9me2/3), then recruits histone methyltransferases (HMTs) like SET 
domain bifurcated 1 (SETDB1) or suppressor of variegation 3-9 homolog 1 or 2 (SUV39H1/2) to 
methylate the same residue on neighboring nucleosomes 1–6. HP1 and H3K9me2/3 are normally 
found at the pericentromere and also along the chromosomes at developmentally- 
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regulated genes in somatic cells 7,8. Heterochromatin is also observed transiently at the sites of 
double-stranded breaks and is important for the Ataxia Telangiectasia Mutated (ATM) double-
stranded break repair pathway 9,10. These markers of heterochromatin, like many other epigenetic 
modifications, have been found perturbed in human disease 11–14. Heterochromatin patterning is 
also very closely connected to another well-studied mark of heterochromatin that is intrinsically 
tied to the underlying DNA sequence, DNA methylation. 
DNA methylation was one of the first epigenetic control mechanisms discovered to silence 
gene expression. Even before the characterization of gene promoters, it was shown that methylated 
DNA adjacent to a gene of interest would repress genes 15. Cytosine residues in the context of a 
CpG dinucleotide are modified by the addition of a methyl group to the 5’ carbon of the cytosine 
nucleotide base. This mark is faithfully propagated from parent to daughter strand during DNA 
replication by a maintenance DNA methyltransferase (DNMT1), though it has been shown that 
the de novo DNA methyltransferases DNMT3a and DNMT3b are indispensable for DNA 
methylation in mouse embryonic stem cells (mESCs) and DNMT3b is indispensable in mouse 
embryo fibroblasts (MEFs) 16–18. In the early 1980s, it was discovered that there were regions of 
the genome that were enriched for the CpG dinucleotide but were, unlike the rest of the mammalian 
genome, not methylated 19. A subset of these CpG islands were methylated during development, 
while another set were found to be in promoters of house-keeping genes and are kept free from 
methylation in differentiated cells 20,21. Appropriate DNA methylation is part of normal cellular 
differentiation during development. DNA methylation is required to silence repetitive genomic 
elements, for X-inactivation in females, for appropriate imprinting of parental alleles, and to 




become inappropriately methylated in diseases, such as cancer, and disrupt gene expression 
programs of the cell 24–30.  
While it is well documented that these two gene-silencing pathways work in tandem, often 
overlapping in silenced regions of the mammalian genome, there is some evidence that the two 
might also have interdependent roles, as is found in other organisms 8,31–36. For example, during 
DNA replication DNMT1 works in conjunction with a RING finger type E3 ubiquitin ligase 
UHRF1 that can bind both hemi-methylated DNA and H3K9me3 to maintain DNA methylation 
in dividing cells 32,37. However, it has been complicated to examine causal relationships due to the 
lack of tools that can study kinetics in the presence or absence of CpG methylation sites. In order 
to determine if an HP1-mediated heterochromatin domain is affected by the underlying DNA 
sequence, or if it can persist in the absence of DNA methylation over repeated cell divisions, we 
devised a system to explore the behavior of an HP1-mediated domain in the presence or absence 
of CpG dinucleotides in the immediate promoter regions of a knock-in reporter. This system uses 
chemically-induced proximity (CIP) to reversibly tether the chromoshadow domain of HP1α 
(csHP1α) upstream of the transcription start site of a reporter gene. The chromoshadow domain of 
HP1 is responsible for binding other proteins, including other HP1 monomers and HMTs, and can 
induce a heterochromatin domain as sufficiently as full-length HP1α 38–40.  By tethering an ectopic 
csHP1α to the gene locus, we were able to chemically initiate a heterochromatin domain across 
the promoter and reporter gene body. In this study, we created reporter cassettes with one of two 
promoters driving a nucEGFP reporter: a wild-type CMV-EF1α promoter (CpGFull) or a “CpG 
depleted” version of the promoter (CpGDep) that is devoid of all CpG dinucleotides 41. 
In order to explore the silencing dynamics and the heterochromatin memory attributed to 




levels. We were surprised that despite the differences in the underlying DNA sequences, initial 
experiments showed both the CpGFull and CpGDep promoters were silenced at roughly the 
same velocity, as defined by hours of CIP-rapamycin csHP1α recruitment required before 
measurable GFP repression and H3K9me3 enrichment. Upon release of short-term csHP1α 
recruitment, the CpGDep and CpGFull cassettes both rapidly lost the heterochromatin domain 
and re-expressed GFP within six days. However, after an extended period of csHP1α-induced 
heterochromatin, the CpGFull promoter alone was able to maintain a silenced state after csHP1α 
release by CIP washout.  
 
3.2. Methods 
Promoters: The CpGDep promoter was obtained from Dr. Michael Rheli, in the plasmid 
pCpGL 865. The sequence was cloned into an expression plasmid containing a nucEGFP reporter 
gene with homology to a region of the β-globin locus kilobases from any other gene and relatively 
devoid of known epigenetic marks; a locus selection that was inspired by others’ previous work 
42. The CpGFull promoter was stitched together by PCR and was designed to mimic the CpGDep 
promoter as much as possible in length and nucleotide composition. All primers used in this project 
are reported in Table 3.1. Homology arm sequences are reported in Supplemental Table 3.S1.  
Plasmid design and generation: The CpGDep and CpGFull expression plasmids were 
created by inserting the respective promoters into the BamHI site of a reporter with ZFHD1 and 
Gal4 DNA binding domains upstream of a nucEGFP (N261), using infusion cloning (Clontech). 
Balb/C-specific homology arms were amplified from genomic DNA of TC1 mouse ES cells. The 
csHP1α-tandem-FRB expression plasmid (P070) was generated by removing the puromycin 
resistance gene from a preexisting csHP1α-tandem-FRB expression plasmid (N163 40, Addgene 




plasmid (P023) was created as described 43. All cloning steps were performed in DH5α or One 
Shot Stbl3 cells (Invitrogen). 
Transformation of mouse embryonic fibroblasts (MEF)s: BALB/c 3T3 clone A31 cells 
(ATCC Number: CCL 163, passage 71) were grown in DMEM High Glucose with 10% Colorado 
Calf Serum and pen/strep at 37°C and 5% CO2. Cells were passaged every 2-5 days, and we kept 
between 30% and 80% confluency. Cells were transformed by the addition of lentiviral-delivered 
Large-T antigen (N234) and continually cultured until cells could be passaged at a 1:20 dilution 
(~3 weeks), which is a signature of transformation of MEF cells. Lines were then switched to fetal 
bovine serum-supplemented growth media, as previously described 44. 
Cell culture and CIP heterochromatization assay: Cells were grown in FBS-supplemented 
growth media (Gibco 26140-079, Lot #1972526) 44 and selected with 9 µg/ml blasticidin and 400 
µg/ml hygromycin to drive csHP1α-FRB and FKBP-GAL4 expression. One day prior to 
experimentation, blasticidin and hygromycin were removed from the cells, which were then grown 
in drug free media. Rapamycin from a 10 µM stock dissolved in ethanol was added to media at 3 
nM concentration.  
Rapamycin washout and addition of 5-aza: Washout of rapamycin was performed by the 
addition of FK506 at 100 nM concentration for 48 hours, which competes with rapamycin at the 
active site of the FK506 binding protein (FKBP). Cells exposed to both FK506 and 5-aza 
simultaneously were exposed to 100 nM FK506 and 5 µM 5-aza for 48 hours, then FK506 was 
removed and the cells were exposed exclusively to 5-aza for an additional 72 hours.  
CRISPR/Cas9 insertion of expression constructs: Cell lines were created using the Cas9 




(P023) and 2.5 µg of one of the reporter plasmids (linearized with KpnI) were co-transfected into 
one million transformed MEFs using an Amaxa 4-D Nucleofector on program EH-100. 
Lentiviral infections: 293T LentiX cells (Clontech) were transfected using 
polyethyleneimine (PEI), as described in 45. Lentiviral infection of Large-T antigen did not require 
antibiotic selection, as transformed cells have a growth advantage and emerge from a sparsely 
populated plate where untransformed MEFs undergo senescence. Lentiviral infection of the clonal 
lines with the csHP1α-tandem-FRB and GAL4-FKBP fusion constructs required an outgrowth 
time of two days before selection with blasticidin (N118, Addgene #44245) or hygromycin (P070). 
Clonal isolation of cell lines: Transfected cells were seeded into a 96-well plate at a dilution 
of 80 cells per 10 mLs of growth media, with 100 µL distributed to each well. The cells were 
grown for two days, then each well was checked for individual cell plaques. Wells with single 
plaques were selected for expansion as clonal lines. Each line was checked for CRISPR insertion 
of the expression constructs using PCR and Southern blot analysis. 
PCR verification of inserts: Genomic DNA was isolated from each line using a previously 
described method 40. Cells were digested with Proteinase K at 400 µg/ml at 56 °C overnight, then 
purified by phenol/chloroform extraction and ethanol precipitation. PCR verification of proper 
insertion was performed with a primer inside the nucEGFP of the expression construct and a primer 
outside of the 5’ homology arm.  
Southern blot determination of inserts: Genomic DNA was isolated from clonal lines and 
treated with Proteinase K at 400 µg/ml at 56 °C overnight, then purified by ethanol precipitation. 
Five µg of DNA for each clone was digested with EcoRI-HF for one hour and twenty minutes, 
before heat deactivation at 65 °C for 15 minutes. Samples were then loaded into a 0.6% agarose 




kit (Roche), and the blot was performed using a DIG Wash and Block Buffer set (Roche) and DIG 
Luminescent Detection Kit (Roche), as per the manufacturer’s instructions. The depurination step 
was not used. Carestream BIOMAX Light Film (Kodak 1788207) was exposed for 2 hours and 
developed with standard methods. 
FACS and flow cytometry: FACS of GFP-expressing cells for each cell line was performed 
by the UNC Flow Cytometry Core on a FACSARIAII (BD Biosciences). The flow cytometry was 
performed on two Attune Nxt machines (Thermo Fisher) in biological triplicate. Due to the 
differences in blue laser intensity, mean fluorescent intensity of GFP expression cannot be directly 
compared between Attune 1 and Attune 2.  Samples were analyzed using FlowJo software. Sample 
gating can be found in Supplemental Figure 1 (Fig 3.S1).   
Chromatin Immunoprecipitation (ChIP): ChIP was performed using a modified version of 
a previously described protocol 46. Briefly, 6 million cells were harvested as described above, and 
crosslinked with 1% formaldehyde for 10 minutes. Sonication was performed in 90 µl of Covaris 
Shearing buffer (0.1% SDS, 1 mM EDTA pH 8, 10 mM Tris HCl pH 8) and 10 µl of a nanodroplet 
cavitation reagent MegaShear (Triangle Biotechnology) as described 47 with a sonication time of 
8 minutes at 200 cycles/burst to produce DNA fragments ~200-500bp. ChIP lysate equivalent to 
five million cells in Covaris Shearing buffer was adjusted with 5x IP Buffer (250 mM 
HEPES/KOH pH 7.5, 1.5 M NaCl, 5 mM EDTA, 5% Triton X100, 0.5% DOC, 0.5% SDS) to a 
salt concentration of 1x. 5 µg of H3K9me3 antibody (abcam ab8898) was added to adjusted lysate. 
40 µL of Protein G Magnetic Dynabeads (Invitrogen cat. #10003D) were washed twice with 500 
µL ChIP IP Buffer (50 mM HEPES/KOH pH 7.5, 300 mM NaCl, 1 mM EDTA, 1% Triton X100, 
0.1% DOC, 0.1% SDS), then resuspended in 40 µL ChIP IP Buffer. Dynabeads beads were added 




day, the beads were collected with a magnetic strip, then washed twice with 1 mL ChIP IP Buffer 
for 3 minutes each wash at room temperature with end-over-end rotation. The beads were then 
washed with 1 mL DOC buffer (10 mM Tris pH 8, 0.25 M LiCl, 0.5% TERGITOL, 0.5% DOC, 1 
mM EDTA), then washed in 1mL TE pH 7.4. The beads were resuspended in 100 µl TE pH 7.4, 
supplemented with 2.5 µL SDS and 5 µL 10 mg/ml Proteinase K (Invitrogen 25530-031), then 
incubated without agitation overnight at 65°C. The next day, supernatant was collected from the 
beads, combined with one wash of 100 µL TE, and purified using the Qiagen MinElute PCR 
Purification Kit (Qiagen ref # 28006). Biological replicates were performed in duplicate. 
qPCR: qPCR reactions were performed using FastStart Universal SYBR Green Master 
Mix (Rox) (Roche 04913914001), 0.03-10 ng of template DNA, and 2.5 µM of each qPCR primer 
(Table 3.1). The reactions were performed in 384-well plates on an ViiA 7 qPCR machine (Applied 
Biosystems). The reaction parameters were the same as previously reported 45, and the CT values 
were normalized to an intergenic region (IGR) 48. Biological replicates were performed in technical 
triplicate. 
Bisulfite sequencing: Bisulfite conversion of DNA was performed using the EpiTect 
Bisulfite kit (Qiagen), as per the manufacturer’s instructions. Up to two million cells were 
harvested per line for each condition. For the 5-week silenced samples, cells were harvested at the 
time of rapamycin removal. A portion of the bisulfite-converted DNA was amplified through PCR 
and cloned into plasmids using the Invitrogen topoisomerase cloning kit (Invitrogen K457502). 
The plasmids were transformed into One Shot Stbl3 cells, and single colonies were submitted for 




Statistical analysis: Statistical analyses were performed using GraphPad Prism 7 software. 
Replicates from flow cytometry and qPCR were subjected to unpaired t-tests, and statistical 
significance was determined using the Holm-Sidak method, with alpha = 0.05.   
3.3. Results 
In order to determine the role of CpG dinucleotides in the kinetics of gene silencing and 
heterochromatin maintenance, we designed two reporter gene constructs with promoters of 
different CpG content. The CpGFull promoter is comprised of a wild-type human CMV 
enhancer and core EF1α promoter sequence and contains 39 total CpG dinucleotides clustered 
closely together. The CpGDep promoter is comprised of a CpG-depleted mutant of a murine 
CMV enhancer and human EF1α promoter, of similar length and GC composition of the 
CpGFull promoter but devoid of CpG dinucleotides (Fig 3.1A and Fig 3.S2). We used 
CRISPR/Cas9 gene editing to insert a nucEGFP gene driven by the CpGFull or CpGDep 
promoter outside of the Hbb-γ gene in the β-globin locus in the mouse genome of large-T 
transformed MEFs 43. We isolated four clonal cell lines for each construct and verified the 
successful genomic insertion with polymerase chain reaction (Fig 3.1B, Table 3.1).  Additional 
insertions into the genome were identified through Southern Blot analysis (Fig 3.S3). We 
excluded the two clones that did show the predicted two kilobase band for our insertion and 
sorted the remaining six cell lines to have uniform GFP expression profiles (S4 Fig). Despite the 
additional genomic insertions, all cells in a population responded similarly to csHP1α 
recruitment followed by release. Therefore, these six lines are appropriate to use for the 
comparison of repression dynamics with these two different promoters. The three cell lines with 
the CpG-depleted promoter we called “CpGDep,” and the three cells lines with the wild-type 




We induced heterochromatinization of the reporter genes using the CIP-based Chromatin 
in vivo Assay (CiA) platform 40. CiA utilizes CIP-rapamycin mediated recruitment of fusion 
proteins to reversibly tether an effector protein to a specific gene locus. The presence of Gal4 and 
ZFDH1 DNA binding sites in the reporter constructs allows recruitment of the chromoshadow of 
HP1α (csHP1α) to the nucEGFP gene in the presence of CIP-rapamycin (Fig 3.1C). CIP addition 
binds the FK506 binding protein (FKBP) fusion with GAL4 at the CiA locus and the FKBP–
rapamycin binding (FRB) domain-tagged csHP1α. Following CIP addition, tethered exogenous 
csHP1α recruits endogenous HP1 proteins and HMTs to perpetuate a heterochromatin domain and 
silence expression of the reporter gene 40. Because the recruitment is dependent on a small 
molecule bridge, it can be reversed by replacing rapamycin with FK506, which binds only to FKBP 
and not the FRB domain tag, helping to rapidly compete off rapamycin CIP and dislodging the 
initial csHP1α nucleation event. This reversibility allows us to investigate the durability of the 
induced heterochromatin domain after short-term and long-term silencing (Fig 3.1D). Once the 
nucleating csHP1α is removed, the heterochromatin domain is left subject to the natural cellular 
processes governing epigenetic memory. 
Induction of heterochromatin in the three clonal cell lines for each promoter was measured 
by the reduction of cellular green fluorescent protein (GFP) levels from the nucEGFP reporter 
gene. Flow cytometry analysis of a cell line over six days of csHP1α recruitment shows a ten-fold 
reduction of GFP after two days based on relative fluorescent intensity of individual cells in a 
population, and almost complete absence of GFP after six days (Fig 3.2A). We then averaged this 
intensity across all the cells in each sample to get the mean fluorescence intensity for that 
population. All six cell lines, CpGDep and CpGFull, followed this pattern of silencing over six 




higher baseline of gene expression before silencing (Fig 3.2A & 3.2B). These data show that the 
two promoter types are repressed at similar time points after the CIP-rapamycin mediated 
recruitment of csHP1α, as measured by gross reduction of GFP levels by the second day. 
In order to investigate if the different promoters contributed to different epigenetic 
architectures upon csHP1α-induced heterochromatization, we performed ChIP-qPCR for 
H3K9me3 enrichment after short-term silencing. We selected two regions along the nucEGFP 
gene body to compare, +420 and +784 bp downstream from the transcription start site (TSS) 
because these sequences were identical in both CpGDep and CpGFull lines. We also designed 
different primers for H3K9me3 enrichment in the promoters of each cell line (Fig 3.3A).  We 
performed ChIP for H3K9me3 enrichment during the six days of csHP1α recruitment and found 
that for both CpGDep D and CpGFull E lines, H3K9me3 enrichment plateaus after 48 hours (Fig 
3.3B). In order to capture the accumulation of H3K9me3, we performed an early time-course 
experiment, cataloging both gene silencing and H3K9me3 dynamics within the first 48 hours. In 
both the CpGDep D and CpGFull E lines, gene silencing is not measurably changed until 12 hours 
after CIP (Fig 3.4A). However, in both lines measurable H3K9me3 accumulation is seen as early 
as three hours post csHP1α recruitment, indicating a lag time between the recruitment of histone 
modifications and ability to measure the decrease of gene expression from the cassettes (Fig 4.4B).  
We next removed the initiating csHP1α tether event by washing out the rapamycin with 
the addition of 100 nM FK506 for 48 hours and performed flow cytometry to determine the 
speed of re-expression from each reporter construct. The CpGDep lines recovered from silencing 
rapidly, completely re-expressing GFP by day four post-rapamycin washout (Fig 3.5A). These 
lines responded to the release from heterochromatin by expressing levels of GFP greater than the 




lines took a full six days to re-express GFP to the same levels as before heterochromatization 
(Fig 3.5B) and did not display the same overexpression behavior as the CpGDep lines. However, 
despite this small difference in re-expression velocity, both the CpGDep and CpGFull clones 
recovered from csHP1α-induced silencing within the span of six days, and neither expression 
cassette harbored any “heterochromatin memory” with prolonged gene repression from this 
short-term silencing. We performed ChIP four days following CIP-rapamycin washout and 
measured a reduction in overall H3K9me3, but not complete ablation of the mark after four days 
of release (Fig 3.5C & 3.5D). The CpGFull line showed a significant decrease in the enrichment 
of H3K9me3 for all three primer pairs tested (Fig 3.5D). For the CpGDep line, however, 
significant reduction of H3K9me3 enrichment was only measured in the promoter (Fig 3.5C). 
This decrease in H3K9me3 in the promoter is likely indicative of why the gene was re-expressed 
so quickly in both cell lines. 
In order to allow for the engagement of the DNA methylation pathway and investigate 
the heterochromatin memory of the promoters, we recruited csHP1α in all six lines 
consecutively for five weeks40. We then performed a similar rapamycin washout as the short-
term silencing experiment, but this time we compared the results of gene re-expression with and 
without the addition of the DNA methyltransferase inhibitor 5-azacitidine (5-aza) for the 
CpGDep and CpGFull lines. The CpGDep lines returned to almost baseline expression, with or 
without the addition of 5-aza, within six days of rapamycin washout (Fig 3.6A). The CpGFull 
lines, however, failed to return to baseline expression after six days of release (Fig 3.6B). The 
addition of 5-aza did improve the re-expression patterns in these cells but was not sufficient to 
re-establish baseline expression. In the two CpGFull lines tested the bulk mean fluorescent 




in this system. Many cells in this HP1 release samples remained in a GFP-negative state for the 
duration of the experiment and remained 3.5-5.6-fold repressed on average after six days of 
csHP1α CIP-tether release. 
We next performed bisulfite sequencing on a portion of the promoter regions of two 
CpGFull clones, which spanned 32 out of the 39 CpG dinucleotides in the CpGFull promoter 
(Fig 3.S5A). After five weeks of CIP-HP1 induced silencing, CpGFull E displayed only 10% 
methylation of cytosines in this region, which remained stable even after CIP-HP1 washout (Fig 
3.S5B).  However, the levels of DNA methylation were too low in these lines to make any real 
conclusions about the contribution of DNA methylation to the sustained silencing in these cells. 
3.4. Discussion and Conclusions 
This work demonstrates the importance of the underlying genetic sequence and CpG 
dinucleotide content to the long-term stability of an HP1-mediated heterochromatin domain. The 
short-term silencing and heterochromatization of our reporter gene were unaffected by CpG 
dinucleotide content of the promoter, as evidenced by gene expression and H3K9me3 enrichment. 
Indeed, CpGDep and CpGFull reporter lines rebounded from heterochromatization within six days 
of csHP1α release, indicating no lasting effects of induced silencing. However, when continuously 
silenced for five weeks, the CpGDep line fully recovered expression levels to the same extent as 
before csHP1α recruitment, while CpGFull reporter lines were unable to recover and restart gene 
expression. As to why the CpGFull lines did not achieve full re-expression after the addition of 5-
aza, it is possible that the experiment did not run long enough to see the return of GFP expression. 
If we had continued to monitor the cells after release, they may have eventually returned to baseline 
expression. However, levels of DNA methylation were too low for us to identify DNA methylation 




these cells silenced. It will be interesting in the future to investigate what other epigenetic players 
might contribute to this heterochromatin memory. 
Past experiments, mostly in the context of mESCs have shown an interdependence of 
histone and DNA methylation at regions of heterochromatin. For example, the DNA methylation 
at the pericentromere of mESCs is dependent upon the presence of the Suv39h histone 
methyltransferases, though the colocalization of HP1α/β with DNMT3a/b is not disrupted at the 
centromere of the Suv39h double null cells 8. This may explain why bulk chromatin compaction 
is not lost in mESCs when DNA methylation is abrogated 50.  More prescient to our work, however, 
is the interaction between DNA methylation, or sequence, and histone methyltransferases in 
regions of traditional euchromatin, such as the direction of DNA methylation of the Oct3/4 
promoter by the HMT G9a, or the colocalization of  SETDB1 and DNMT3a at the promoter of  
p53BP2 in HeLa cells 51,52. Because of the modular nature of this system, we can explore any 
region of the genome that may become silenced in a disease context.   
Our work shows that csHP1α-induced heterochromatin cannot remain silenced at a 
controlled locus in the absence of CpG dinucleotides. In the past, many groups have used CpG-
depleted transgenes in the hopes of evading DNA methylated-silencing by the cell 53,54, but those 
studies were focused on maintaining gene expression from the CpG-depleted genes, not on actively 
suppressing it to study HP1-specific heterochromatin memory as we can do by CIP-csHP1α 
recruitment. In our work, by intentionally inducing heterochromatin to two different promoter 
substrates, we can measure the specific contribution of DNA sequence to HP1-induced 
heterochromatin repression in the absence of other factors in a physiologically relevant setting. In 
this, we have created a powerful tool that can be used to further study the importance of underlying 




Armed with this model system, we can explore the importance of time in establishing 
repressive domains. Because DNA methylation can become so misregulated in disease, there is a 
strong push to alter the chromatin landscape of endogenous genes with chromatin modifying 
machinery 55–58. From our controlled system, we found that DNA sequence bears no impact on 
the speed with which you can initially induce a heterochromatin domain; csHP1α is well capable 
of establishing a repressive heterochromatin domain when CpG sites have been depleted from 
the promoter. However, to achieve durable repression after initial csHP1α stimulation, direct 
CpG methylation sites are required. We hope to use this new and modular system to explore 
other regulatory gene expression pathways in different genomic contexts in differentiated cells.      
In conclusion, we here provide evidence that the underlying genetic sequence itself can 
affect protein-driven epigenetic gene repression. We found that when CpG residues are removed 
from the immediate promoter region of a reporter transgene, CIP-mediated HP1 gene repression 
loses the ability to maintain durable gene silencing after release of the csHP1α initiating protein 
from the promoter by CIP washout. We also provide a new resource to study the contribution of 





Table 3.1.  Primers used for plasmid construction and qPCR.   
 




Inside reverse sewing primer 
to create CpGFull promoter 




Inside forward sewing primer 
to create CpGFull promoter 




Outside reverse sewing 
primer to create CpGFull 





Amplify CpGFree promoter 




Amplify CpGFree promoter 




Amplify CpGFull promoter 




Amplify CpGFull promoter 
for infusion into N261 
sgRNA PV001 CACCGTGTCTGCTCTGA
ACTGAAA 
Oligo to create sgRNA and 
anneal into CRISPR delivery 
plasmid 
sgRNA PV002 AAACTTTCAGTTCAGAG
CAGACAC    
Oligo to create sgRNA and 




Primer inside of nucEGFP to 





Forward primer to amplify 
Balb/C homology arm 2 for 




Reverse primer to amplify 
Balb/C homology arm 2 for 




Forward primer to amplify 
Balb/C homology arm 2 for 




Reverse primer to amplify 
Balb/C homology arm 2 for 






Primer upstream of 5’ 
homology sequence to 





Bisulfite sequencing primer 
for CpGFull promoter 
PVP234 TATATACRATTCTCCCCC
ACCCTC 
Bisulfite sequencing primer 
for CpGFull promoter 
489_2s GCGCACCATCTTCTTCAA
GG 








ChIP primer in nucEGFP 
gene body and polyA 
738_1as ATCTAGAGTCGCGGCCG
G 
ChIP primer in nucEGFP 
gene body and polyA 
IGR_5s CGTGTCTGTCGGGGCTTT
T 





























Figure 3.1 Creation of CpGDep and CpGFull reporter cell lines to test effects of CpG dinucleotide content on the kinetics of 
HP1-induced heterochromatization and gene silencing.  A) The wildtype CMV/EF1α promoter has 39 total CpG dinucleotides, 
represented by lollipops, while the CpGDep is completely devoid of CpG sites. B) GFP-expression cassettes are driven by the 
CpGDep or CpGFull promoters inserted into an intergenic region outside of the Balb/C β-Globin locus using CRISPR/Cas9 targeted 
insertion. Verification of successful knock-in was performed by PCR. PCR primers are indicated by black arrows and can be found in 
Table 3.1. C) The CiA system uses CIP-rapamycin to recruit csHP1α to the reporter gene in a reversible manner. D) The timeline for 
“short-term” silencing is six days of csHP1α recruitment, followed by washout of rapamycin and addition of FK506. “Long-term” 




Figure 3.2.  Recruitment of csHP1α induces silencing of GFP expression. A) Representative 
histograms show reduction of relative GFP levels as measured by flow cytometry in CpGDep D 
and CpGFull E cell lines during csHP1α recruitment. B) Mean fluorescent intensities of CpGDep 
and CpGFull clonal cell lines during csHP1α recruitment, averages of three biological replicates 











Figure 3.3.  Enrichment of H3K9me3 in two cell lines during six days of CIP. A) Position of 




arrows, and primer sequences can be found in Table 3.1. B) Relative H3K9me3 enrichment for 
each primer set at days 0, 2, 4 and 6 post CIP. Each sample contains two biological and three 
technical replicates, n = 6. ** P ≤ 0.01. *** P ≤ 0.001. Significant difference between Day 0 and 









Figure 3.4. Gene silencing and Enrichment of H3K9me3 in two cell lines during 48 hours of 
CIP. A) Reduction of GFP expression as measured by flow cytometry over a period of 48 hours 
in CpGDep D and CpGFull E cell lines on Attune 2.  B) Relative H3K9me3 enrichment over the 
first 48 hours of CIP. qPCR primers are the same as used in Fig 3.3. Each sample contains two 
biological and three technical replicates, n = 6. ** P ≤ 0.01. *** P ≤ 0.001. Significant difference 









Figure 3.5. Recovery of gene expression after short-term heterochromatization. A) Re-expression of the silenced reporter in the 
CpGDep lines, as measured by relative GFP fluorescence on Attune 1 in biological triplicate, n=3. Cells were harvested at days 2, 4 
and 6 post csHP1α washout and analyzed by flow cytometry. Dotted lines represent baseline expression of GFP in each cell line not 
exposed to rapamycin. B) Same as A but using the CpGFull cell lines. C) Enrichment of H3K9me3 in CpGDep D cell line four days 
after CIP release compared to unsilenced and day 6 CIP. D) Enrichment of H3K9me3 in CpGFull E cell line four days after CIP 
release compared to unsilenced and day 6 CIP. qPCR primers are the same as used in Fig 3.3. Each sample contains two biological and 







Fig 3.6. Recovery of gene expression after long-term heterochromatization. A) Re-expression of the CpGDep A and CpGDep D 
cell lines after five weeks of csHP1α-induced silencing, with or without the addition of 5-aza. B) Re-expression of the CpGFull E and 
CpGFull G cell lines after five weeks of csHP1α-induced silencing, with or without the addition of 5-aza. Dotted line represents 
baseline expression for each cell line. Flow cytometry was performed in biological triplicate on Attune 1. n = 3, ** P ≤ 0.01. *** P ≤ 
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Figure 3.S1 Example gating of MEF cell lines in FlowJo software.  Gating strategy, using CpGFull E cell line as an example on 
Attune 1. A) Forward scatter vs. side scatter to distinguish the live cell population. B) Forward scatter area vs. Forward scatter height 
to distinguish single cells from doublets. C) Blue laser channel area vs. violet laser channel area to exclude any cells that may be auto-





Figure 3.S2. Sequence alignments of the CpGFull and CpGDep promoters. A) Sequence 
alignments of the CMV enhancer portions of each promoter. B) Sequence alignments of the 








Figure 3.S3. Southern Blot for genomic GFP insertions in eight clonal MEF cell lines. All 
eight original clonal lines were assayed for random insertion of the reporter constructs using a 
DNA probe against the gene body of nucEGFP. Genomic DNA was digested with EcoRI-HF, 
and probe detection was performed by DIG luminescence exposed to light film. Intended 






Figure 3.S4. Pre-sort GFP expression of six clonal MEF cell lines. Pre-sort expression 
profiles of the six clonal lines chosen for this study. A narrow window of GFP expression was 
chosen (x-axis, GFP-A) in order to normalize GFP expression profiles for all six lines. The P4 
for the CpGFull E clone also denotes GFP+ cells but was labeled differently because it was a 









Figure 3.S5. Bisulfite sequencing of the promoter region of two CpGFull clones. A) A region of 32 CpG dinucleotides denoted by 
red circles was analyzed for DNA methylation by bisulfite analysis. B) The DNA methylation profile of the CpGFull E clone repressed 
by CIP-csHP1α, after five weeks of silencing, after HP1 washout with FK506, and with the addition of 5-aza. C) CpGFull G.  Red 
squares represent methylated cytosines. White square represents a mutated cytosine where DNA methylation state could not be 




CHAPTER 4: Discussion 
4.1. Conclusions 
Transcriptional regulation of a gene relies on a myriad of interacting molecular 
components. Cis regulatory DNA sequences like promoters and enhancers are bound by 
transactivating proteins that recruit or permit the recruitment of the RNA polymerase 
transcriptional apparatus, and the histone proteins that spool DNA are post-translationally 
modified with covalent adjuncts that relax or restrict the accessibility of the underlying sequence 
1,2.  Understanding how these two levels of regulation interact is an ongoing study because there 
are few known DNA sequence motifs that have been demonstrated to directly recruit proteins to 
modify the chromatin architecture. In Saccharomyces cerevisiae, the “silencer” sequences HMR-
E and HMR-I that flank the unexpressed copies of the mating type genes are bound by proteins 
that recruit the histone deacetylase Sir2 3, and in Drosophila melanogaster the polycomb 
response elements (PREs) elements recruit polycomb group (PcG) complexes to the DNA where 
they help regulate the expression of developmental genes 4. Recently “mammalian PREs” have 
been reported that can recruit PcG and/or trithorax group (TrxG) proteins in human cells 5 and 
the human genome contains over one thousand putative copies of the repressor element 1 (RE-1) 
that recruits the repressor element 1-silencing transcription factor (REST) and its associated 
chromatin modifying enzymes in rats 6. However, the best example of DNA sequences that are 
directly associated with chromatin modifying enzymes in the human genome are CpG islands.  
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“CpG island” does not describe a specific sequence motif, per se, but instead describes a 
region of DNA that displays an enrichment of CpG dinucleotides. These islands are typically 
found in the promoters of house-keeping genes and, unlike most of the mammalian genome, 
remain free of DNA methylation 7. Proteins like the lysine methyltransferase 
KMT2A/MLL1/ALL-1 specifically bind non-methylated DNA in the promoters of genes and 
help maintain a domain of active H3K4me3 histone marks 8. Conversely, proteins that have a 
specific affinity for methylated DNA have been shown to interact with chromatin modifying 
enzymes that induce transcriptional silencing, like the methyl CpG-binding domain (MBD) 
protein MeCP2 interacting with the mSin3a/HDAC corepressor complex 9. Methylation of a 
CpG island results in repression of the corresponding gene and the DNA methyltransferases that 
deposit and maintain this methylation provide another connection between the composition of 
the underlying DNA sequence and the suite of effector proteins that comprise the cellular 
epigenetic machinery 10,11.  
Regions of constitutive heterochromatin are typically marked by DNA methylation, 
H3K9me3 and heterochromatin protein 1 (HP1) 12. Multiple lines of evidence have shown that 
the chromatin reader HP1 proteins physically associate with both DNA and histone 
methyltransferases 13–16, but previous studies in our laboratory have proven that recruitment of 
the non-enzymatic HP1α protein can induce gene silencing and heterochromatin domains marked 
by both H3K9me3 and DNA methylation 17. Recruitment was made possible by the construction 
of the Chromatin in vivo Assay (CiA), which reversibly tethered the chromoshadow domain of 
HP1α (csHP1α) to the highly-regulated, CpG island-containing Oct4 promoter. While this assay 
was ideal for exploring the kinetics of heterochromatin formation and memory at Oct4, it was 
stably integrated into the Oct4 locus was therefore not amenable to easy manipulation of the 
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surrounding regulatory sequences. The stringent, cell-type specific regulation of Oct4 also made 
it difficult to explore chromatin regulators that induce more modest changes in gene expression.  
In order to compare how different chromatin modifiers can alter the transcriptional output 
of a gene, and how differences in the underlying DNA sequences can affect the stability of those 
changes, we have created a second generation of the CiA (CiA 2.0). CiA 2.0 is modular and each 
component of the reporter gene cassette is exchangeable, including the promoter, the reporter 
gene, and the homology arms used for genomic insertion with the CRISPR/Cas9 system.  
Effector proteins are reversibly tethered to GAL4 or ZFHD1 binding arrays upstream of the 
reporter gene in a chemically-dependent manner using a pair of fusion proteins that bind the 
small molecule rapamycin. Using this new assay, we compared the gene silencing ability of the 
three mammalian isoforms of HP1 with that of m-phase phosphoprotein 8 (MPP8). We 
demonstrated that all three mammalian HP1 isoforms were equally efficient at repressing 
transcription from our system, but that MPP8 was both slower to repress and did not achieve full 
repression of the reporter gene after six days of recruitment. We also demonstrated that HP1-
silenced reporter genes returned to baseline expression after six days of HP1-induced silencing, 
but that MPP8-silenced genes responded to transcriptional reactivation by expressing at levels 
almost twice as high as before MPP8 recruitment.  
We next used CiA 2.0 to explore the influence that promoter structure has on the ability 
of a given chromatin modifier to induce heterochromatin formation and sustained gene silencing. 
What we saw was that expression from a wildtype “CpGFull” promoter and a promoter depleted 
of CpG dinucleotides “CpGDep” responded to induced gene silencing from csHP1α identically, 
displaying reduced gene expression 12 hours after induced silencing and increased H3K9me3 
enrichment three hours after silencing. Upon release of the csHP1α, both promoters lost 
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H3K9me3 enrichment and reactivated normal gene expression within six days. However, like the 
MPP8-silenced genes from above, the genes driven by the CpGDep promoter exhibited hyper-
activated transcription after release from csHP1α. After an extended period of silencing that 
lasted five weeks, transcriptional reactivation of the CpGFull promoters was minimal, and was 
marginally increased by the addition of the DNA methyltransferase inhibitor 5-azacitidine (5-
aza). However, the CpGFree promoters resumed unimpeded transcriptional activation after six 
days, and were unaffected by the addition of 5-aza.  
These results demonstrate the utility of CiA 2.0 to compare the contribution of both 
chromatin effector proteins and cis regulatory sequences in the formation of stable chromatin 
domains. 
 
4.2. Future directions 
Future work with this system is required to determine the mechanism of long-term 
silencing exhibited by csHP1α-induced silencing of the CpGFull promoter. We predicted that 
any permanent silencing of the promoter would be conferred by the gain of DNA methylation, as 
was true for the Oct4 promoter, however bisulfite sequencing data showed that only minimal 
DNA methylation was accrued after five continuous weeks of silencing, and the addition of the 
DNA methyltransferase inhibitor 5-aza failed to completely recover baseline transcription from 
the cassette. Therefore, there is likely another mechanism of gene silencing at play that is 
dependent on the structure of the CpGFull promoter but does not rely on CpG methylation. The 
first step in this investigation should be to determine if H3K9me3 is lost from the CpGFull 
promoter after release from long-term silencing, since that was not examined. If H3K9me3 does 
indeed disappear after CIP release, the presence of any other known chromatin repressive marks 
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such as H3K9me2, H3K27me3, H4K20me3 or the lingering presence of any isoforms of HP1 
should be determined 18. The most likely explanation for continued silencing is that repressive 
transcription factors, in the vein of the KRAB-Zinc finger proteins, remain bound to sequences 
of in the CpGFull promoter that are absent in the CpGFree promoter. Disruption of one or more 
key DNA sequence binding motifs in the CpGFull promoter may be all that is required to abolish 
long-term epigenetic silencing. Tissue-specific gene expression is complemented by tissue-
specific gene silencing: individual cells must maintain permanent silencing of all the genes that 
are not required for the function of that cell type. Mutations in the regulatory sequences that 
confer this regulation can result in diseases like β-Thalassemia, Hemophilia-B, and thyroid 
cancer 19–21. The modular nature of the CiA 2.0 will continue to allow for side-by-side 
comparisons of promoter architecture and mutations.   
Intriguingly, the most interesting phenomenon reported here took place in two different 
studies, with two different promoters. In Chapter 2, we demonstrated that recruitment of MPP8 
to a wildtype CMV/EF1α promoter, called CpGFull in Chapter 3, resulted in incomplete 
silencing of our reporter cassette, and an anomalous hyper-expression of the gene after release of 
CIP. This phenomenon was not present in either study where the CpGFull promoter was 
repressed by HP1, however is was present in CpGFree promoters repressed by HP1. As of this 
moment, the mechanism of over-expression during rebound transcription remains undetermined. 
Unlike at Oct4, we did not test for the disappearance of the activating histone mark H3K4me3 in 
either of these studies 17. It is possible that in both these circumstances a bivalent chromatin 
domain is formed, poised for reactivation, as opposed to strictly repressive heterochromatin 
domain. It will be interesting to investigate the cause of this rebound transcription, especially 
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because so many groups, including ours, are interested in the ectopic silencing of endogenous 
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